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Dom34:Hbs1複合体のNo-Go Decayにおける機能解析
と標的mRNAの解析
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(nonsense-mediated decay˛NMD) (Kervestin et al., 2012)8ȱǀSeAƾĭħȀ
Ȁő mRNAǯȀȃÕɫȬ%=jYdar´ĴÕɫȬ(non stop decay˛NSD) (van 
Hoof et al, 2002)Ɂɱ«ʮʲļ)´Ĵ mRNAÕɫȬ(No-Go decay˛NGD) (Doma 
and Parker, 2006)('*ȎȚ):<Ƙ;)>$ 
 Ȕ+No-Go Decay)ʱ=Ĕĳ&$Ȍ;>$	Dom34:Hbs1ɣĂ°mRNA
čʅȦǶƽƷ*"%= No-Go Decay )'*:
)ʱ$	=*AƘ;)
=&AȆȃ)ɫƭAɞ!;)ɫƭ*ʛȖ%ƒ)ɥ"! mRNA *
ÕĳÍÖƑ*ÕĳƽƷAɵȯ)ɫƭ=&% No-Go Decay *ȯɇǸǶĵȃ(űȿ
AƘ;)%=*%+(	&ɂɵȯ(ɫƭAɞ! 
 
1. Dom34:Hbs1ɣĂ°* No-Go Decay)=ÕĳƽɈ*ɫƭ  
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NSD* 2"*ȳʊ)	$NGD* 5’¾ÖƑƑǬö-jYdar mRNA*Õɫ
)ʱ$	=AƘ;)=&AȆȃ)ɫƭAɞ!kysaewV
F{ʡ×ˑRz˒A GFP *ǔ)ſÈ ŋȃ( 5’-NGD ʰǹǮĄƸ)ȱǀSe
Až(	GFP-Rz mRNA AȂǵ*ɁɱǹǮAɫƭ*ȴƮ
dom34ΔħȀư)	$GFP-Rz*ɁɱǹǮx]{ǾÕ)Ĵę"ur`
X tRNA &$ƵÔ>3Dom34:Hbs1 ɣĂ°):<IM]hOD
\):= 5’-NGD ʰǹǮ*Õɫµʙ>;)Dom34:Hbs1 ɣĂ°+x
(A)ʬAž"jYdar mRNA *Õɫ7µʙ§*ȴƮ;Dom34:Hbs1









ɣĂ°):<Õɫµʙ>= CBP1 mRNA ÕĳÍÖƑAû=&Ȓď>
6*ÕĳƽƷ*ɫƭAɞ!CBP1 +Ʊ)Se>zdSeDy
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D\ǓŮħȀư-) Sen54*zdSeDňęħȀư)	$ÕĳÍÖƑ













































˕−˕ ɤƖ  
 










ǔ)ſÈ ŋȃ( 5’-NGD ʰǹǮĄƸ)ȱǀSeAž(	GFP-Rz 
mRNA AȂǵ*ɁɱǹǮAɫƭ*ȴƮdom34Δ ħȀư)	$
GFP-Rz *ɁɱǹǮx]{ǾÕ)Ĵę"ur`X tRNA &$ƵÔ
>3Dom34:Hbs1 ɣĂ°):<IM]hOD\):= 5’-NGD ʰǹ
Ǯ*Õɫµʙ>;)Dom34:Hbs1ɣĂ°+x(A)ʬAž"jYdar
mRNA *Õɫ7µʙ§*ȴƮ;Dom34:Hbs1 ɣĂ°ȯɇÍ)	$







˕−˖ ŕɽ  
 





ˑFig. 1-1 ˒ɤ(ȯɇʅ mRNA*Õɫȳʊ+x(A)ʬ*ȍʬç;ʯĲ>=ˑ Fig. 
1-2 ˒x(A)ȍʬç*š3’; 5’Ɠą*ÕɫIM]]{):<ˑ Raijmakers et al., 
2004 ˒cM~aoP& 5’; 3’Ɠą*Õɫ Dcp1/2ö- Xrn1):<ˑColler and 
Parker, 2004˒ɞ@>=>§Ĩ)7ȍʬçˁ´Ĵ*cM~aoPȳʊˑBadis et 
al., 2004˒ö-hOJ`eʬÖƑÕɫȳʊˑYang and Schoenberg., 2004˒*Ĵęġ
ĉ>$	= 
 Ɠȯɇ)+Ȁő mRNAčʅȦǶƽƷĴęȀő mRNAAŭʖ)Õɫ=
ˑFig. 1-6 ˒ơ7:ɫƭ>$	=7*f[YħȀ´ĴÕɫȬˑNMD, 
Kervestin et al., 2012 %˒<ORF)ȱǀSeǸȀő mRNA*ÕɫAµʙ
=3ȱǀSeAƾĭȀő mRNA *ÕɫȬ&$jYdar mRNA
ÕɫȬˑNSD; Frischmeyer et al., 2002; van Hoof et al., 2002 ˒ORF%½ǡw]
{):<Ǹ= No-Go mRNAÕɫȬˑNGD; Doma and Parker, 2006˒Ĵę= 
 
˖˒ x(A)ȍʬç  
 
 x(A)ʬ)+x(A)ȴĂ^mOʅˑPABP˒ȴĂ=PABP +ɁɱâǴ&
mRNAĶĹŮ*(ǍĹĔĳ%=6x(A)ȍʬç+Ɂɱˑ de Moor and Richter, 
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2001˒&ÕɫˑChen et al., 1995˒AÚŤ=ǵę3%)˗"*x(A)ȍʬçʢȮ
CCR4/CAF1PAN2/3PARN ġĉ>$	=>;*Ĕĳ+Ɂɱ)7ʱ@<
>;*Ĕĳx(A)ʬ):= mRNAÕɫ&Ɂɱ*ÚŤAɞ!$	=&ɂ;>$
	=CCR4/CAF1 +ȊƱǸǮ)=(x(A)ȍʬçʢȮ%<ˑTucker et al., 
2001, 2002; Temme et al., 2004; Yamashita et al., 2005 ˒3PABP&ìɻȃ)Â
&%ɁɱAµʙ$	=³ġĉ>$	=ˑ Tucker et al., 2002 ˒ƓPAN2/PAN3
+ʋÐš* mRNAŵǩʛȖ)	$x(A)ʬ*ȍʬçAɞ!$	=&ɂ;>$	
=ˑBrown et al., 1996; Mangus et al., 2004 ˒PARN+* mRNA*WYʡ×):<
*x(A)ʬ*ÕɫAÚŤ$	=ˑGao et al., 2000 ˒Ɠ%x(A)ʬ*ȍʬç*
4>3%ġĉ>$	=ÕɫȬ*%Đþʔȃ(øū%=&Ȓ>$




˗˒ 5’3’Ʀȟ;*ÕɫȬ  (Fig. 1-2) 
 




ˑBrown and Johnson, 2001 ˒3Ski7+ eEF1A(elongation factor 1A)Ƹ GTPasee|




ˑFrischmeyer et al., 2002; van Hoof et al., 2002 ˒IM]]{+Ņ(&7 11¸
*^mOʅ;Ʒŵ>=ˑRaijmakers et al., 2004 ˒*ũ+ RNase PH domain
Až" 6 ¸*^mOʅˑPM-Scl75/Rrp45Rrp41Rrp42Rrp46OIP2Mtr3˒)
:<Ʒŵ>=3IM]]{+ƱÍ)	$ 5.8S8 7SL RNA('*ń(
RNA*ŵǩç)ʱ$	=ˑ Allmang et al., 1999; Grosshans et al., 2001 ˒ 
 Ɠȯɇʅ)= 5’; 3’Ɠą/*Õɫ+cM~aoP& 5’; 3’Ɠą
/* Xrn1 *Õɫ):=ˑColler and Parker., 2004 ˒ʢǇ)	$cM~aoP+
Dcp1&ǓŮe|FAž"Dcp2cM~aoPµʙĔĳ):<Od>=
&):<řʇ>=ˑSteiger et al., 2003 ˒cM~aoPµʙĔĳ&$+
Lsm^mOʅȾˑTharun and Parker., 2001; Tharun et al., 2005 ˒Edc^mOʅȾ
ˑDunckley et al., 2001; Schwartz et al., 2003; Kshirsagar and Parker, 2004; Fenger-Gron et 
al., 2005 ˒Dhh1sK\ˑ Coller et al., 2001; Ficher and Weis, 2002; Coller and Parker, 
2005 ˒Pat1ˑ Bonnerot et al., 2000; He and Parker 2001; Coller and Parker, 2005 ˒GW182
ˑRehwinkel et al., 2005˒ġĉ>$	=*ƽɈ+Ïʮȃ%<"*Ĕĳ
Aƾƅ$7cM~aoPƾĭ=&+(	ãǮȯɇ)	$+;)
Dcp1& Dcp2AȻ HedlsŪɤ%=ˑFenger-Gron et al., 2005 ˒cM~aoP
šmRNA+ 5’; 3’Ɠą/IM]hOD\%= Xrn1):<ŭʖ)Õɫ>
=ˑMuhlrad et al., 1994 ˒ 
 
˘˒ NGD (No-Go Decay)˛ ŋȃ(ƿƷʗAž" mRNA*čʅ
ȦǶƽƷ  
 
  ŋȃ(ƿƷʗAž"mRNA+Ɂɱ)´ĴmRNAÕĳÍÖƑˑ NGD: No-Go 
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(Doma and Parker, 2006; Chen et al., 2010; Kuroha et al., 2010; van den Elzen et al., 2010)
NGD +w]{*½ǡʡ×*ʑ¿%ÕĳÍÖƑřʇ>=&ǯŧ
ȃ%=Ɠ%*ÕĳÍÖƑAɞ





 *ÕĳƽƷ)	$ˎ ȢȊƱǸǮ%+Ņ(&7Pelota(ÔɔʢǇ%+ Dom34)












GTPase ǓŮ mRNA ÕĳÍÖƑ(NGD))Ū˅%=+ƥʁɽ>$	=(Fig. 
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Sm-fold ^mOʅ+ RNA ȴĂɈAž RNA &*ȴĂĝ*Ʒʗɫƭ(>$	
=(Kobayashi et al., 2010)(;*ȴĂ)ʦɤ(ǃĠ+ Dom34)+¶Ĵ
>$	(	3eRF1 *ur`XdYpH\ǓŮũ)¶Ĵ>=
GGQ }`p+ Dom34 )+Ĵę(	6eRF1 &+Ȁ(!øūA=
(Shoemaker et al., 2010);)* Pelota& Hbs1*ȴĂƸŘ7ƥɫƘ%= 
 Ɠ%* NGD *ÕĳƽƷ)ʱ=Ĕĳ&$ɂ;>$ Dom34:Hbs1
ɣĂ°+ɳˌȦÍøūȬ)	$Ɂɱ ORF%½ǡw]{* mRNA
;*ɫʽ)Ū˅%=&Ȃɠ>(Shoemaker et al., 2010)3Dom34:Hbs1
*v}P+ˎȢȊƱǸǮ)7Ĵę=>;'*:
)ÕĳÍÖƑ)ʱ
=+Ƙ;)(!$	(	kI)	$ Dom34 *v}P%= Pelota *ƾƅ
Ʃ¨%+ɆŮɎǂ)(=&ġĉ>$	=(Adham et al., 2003) 
 




$	=(Fig. 1-6; Dimitrova et al., 2009; Kuroha et al., 2010)(;ȊƱǸǮ)
	$*čʅȦǶƽƷ/*ɁɱDYd*ʦɤŮ+ƥɫƘ%!ŝȎȚĻ%
+x(A)ʬ*Ɂɱ):!$Ǹ=xW(poly K) :<Ɂɱ«ʮ*½ǡʇ












Ƙ;)(Kuroha et al., 2010)RACK1+ȊƱǸǮ)Ŕ¶Ĵ>$	=^mO
ʅ%(Nilsson et al., 2004)ĩƸ( SrcMf\WPfPȳʊ*ʉĢ^mOʅ&
(=&(Chong et al., 2005)Ďˊ%+rbFMf\ C*ƈž^mOʅ&
(=&(Cox et al., 2003)Ȍ;>$	=3ŮǍĹ8ȯɇĥǄɻȧv}ū
ȣøū('ȂǸ*ȳʊ)7ʱ$	=(McLeod et al., 2000; Kadrmas et al., 2007; 
Guo et al., 2009)RACK1+ 40Sw]{^mOʅ*ƷŵĔĳ%<ʒ*:

(WPfPȳʊɁɱ*âǴ8Ɂɱ*ǯȀŮAÚŤ$	=þɈŮȒď>
$	=(Cox et al., 2003; Gerbasi et al., 2004; Coyle et al., 2009)OFJʾĳˉŦʭ):
=ɩĿȴƮ;RACK1 40SUqgad* mRNAÔüdiʑ¿)ȴĂ$
	=&Ƙ;)(!$	=(Sengupta et al., 2004; Taylor et al., 2009);)Ď
ˊȯɇ%+RACK1*ȴĂrbFMf\CɁɱʯĲĔĳ eIF6&ȴĂ
Ɂɱ*ʯĲAÚŤ$	=&Ƙ;)(!$	=(Ceci et al., 2003) 
 ʒ*:
)ƒǸxur`eʬ):=ɁɱDYd+ mRNA *ÕĳÍÖƑA
řʇ(Dimitrova et al., 2009)*ÖƑ+ Dom34:Hbs1ɣĂ°)+´Ĵ







˚˒ ƧȎȚ*Ȇȃ  
 






&AƘ;)ˑInada and Aiba, 2005; Ito-Harashima et al., 2007 ˒ 
 ʑœŝȎȚĻ&ƫīĵǤƤȎȚĻ*ËĄȎȚ):<NGDˑNo-Go Decay˒*
Ĕĳ&$ĄĹ> Dom34ö- Hbs1x(A)ʬAƾĭmRNA;*^m
Oʅ*ɁɱAµʙ$	=&Ƙ;)(!(Kobayashi et al., 2010)ǯ)
Dom34:Hbs1ɣĂ°ɳˌȦÍøūȬ)	$Ɂɱ ORF%½ǡw]{
* mRNA;*ɫʽ)Ūɤ%=&(Shoemaker et al., 2010)Ƙ;&(<w
]{*ɫʽƽƷ)"	$NGD& NSD)ËʕƽƷÂ	$	=þɈŮɂ
;>$	=NGD):<Ǹ= 5’¾ÖƑƑǬ+ȱǀSe&x(A)ʬAž(	
jYdar mRNA%<Dom34:Hbs1ɣĂ°jYdar mRNA* 3’Ʀȟ%
½ǡw]{*ɫʽ;)+* mRNA *Ɂɱ8ĶĹŮ)ʱ$	=
þɈŮɂ;>=ƧȎȚ%+ʘȶDzjʣʡ×):= mRNA ÕĳÍÖƑ





˕−˗ ȴƮ  
 
Dom34:Hbs1 ɣĂ°+ȱǀSeAƾĭ mRNA * 3’Ʀȟ%½ǡ
w]{Aɫʽ=  
 
 ơʑŝȎȚĻ%+ Dom34:Hbs1 ɣĂ°ȱǀSeAƾĭ mRNA *^m









ǛŅ=&;) Dom34* decoding centerʠ­*ħȀ° F47Aö- Δ(F47-T60)





ski2Δdom34Δ ħȀư%+}j]{ǾÕʑ¿) GFP ^mOʅəȘ$	=&












Dom34:Hbs1 ɣĂ°+ȱǀSeAƾĭ mRNA *IM]]{
):=ÕɫAµʙ=  
 




 mRNA *ÕɫÚŤAɞ!$	=þɈŮ=&ɂƿ*ĺˌAɞ!Figure. 
1-11A)Ȓ GFP mRNA*āˆĞ)kFq_FZ= DIGƹʀ G1G2G3
rqAǺ	GFP-Rz mRNA)ŀ$jVqabEPAɞ!*ȴƮ
dom34ΔħȀư)	$ mRNA* 3’Ʀȟ% mRNA*ƑǬçǸ$	=&ɩĿ
>(Fig. 1-8A, B)*ȴƮ+ƑǬ*ī: 30nt%=&;mRNA
* 3’Ʀȟ%w]{½ǡ*ȴƮ&$w]{*ī&) mRNA
ƑǬç$	=&AȒď$	= 
 ƿ)Ŷ+ Dom34:Hbs1 ɣĂ°*ȱǀSeAƾĭ mRNA *ĶĹŮ)=
ş˂AƵɮʋÐA½ǀȳƚȃ)UrPRNA UrAjV
qabEPĹʨ=&%x^mRNAȂǵʨ*ħçAǝĹëǛƣA
ȥÔ*ȴƮdom34ΔħȀư(4.6 min)hbs1ΔħȀư(3.8 min) 	$ʧǸ
ư(2.2 min) ǈ0$ mRNAĶĹç;)5’¾;*Õɫ)ƾƅAȒ xrn1Δ













=&;(8.6 min -> 5.9min)*òĔAƘ;)=6Fig. 1-8AB%ĄĹ
ƑǬç mRNA*ĶĹŮAɩĿ*ȴƮdom34ΔħȀư)	$ńƑ








řʇ(Dimitrova et al., 2009)*ʡ×ʑ¿% mRNAÖƑ>=&AƘ;
)(Kuroha et al., 2010)*ȎȚ*ʛȖ%12¸*ʘȶDzjʣʡ×A GFP








 PWdrdpC*ʘȶʡ×):= mRNAÕĳÍÖƑ)Ūɤ( mRNA
*ʡ×Aɥ	ĺˌAɞ!PW(GGN)drdpC(UGG)*ʘȶʡ×




























Dom34:Hbs1 ɣĂ°*PDg(G)-rich ʡ×Až" mRNA *ÕĳÍÖƑ/*ĽAƘ
;)=6Fig. 1-10A)Ȓ>ħȀư) p416GPDp-GFP-(GGN)12-FLAG-HIS3
rYzeAŃÈjVqabEPAɞ!*ȴƮÕĳÍÖƑ):
=ÕɫʰǹǮski2Δ ħȀư%ɩĿ>= 5’ÖƑƑǬxrn1Δ ħȀư%ɩĿ>
= 3’¾ƑǬË)ǛŅ6Dom34:Hbs1ɣĂ°+(G)-richʡ×*ÕĳÍÖƑAµʙ
=&Ȓď>Ɠ5’-NGD ʰǹǮ(5’NGD-IM)+ Dom34 ƾƅ)	







Dom34:Hbs1ɣĂ°+jYdar mRNA*ÕɫAµʙ=  
 




(van Hoof et al., 2002)xrn1ΔħȀư)	$ his3-ns mRNA*x(A)ʬ¥à)"
	$Ƶɮ=&ĩ* mRNA +x(A)ʬ¥à>ǰų%əȘ$	(Fig. 
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1-15 lane 11, 12)Dom34:Hbs1ɣĂ°+ȱǀSe*ƾĭ mRNA*ÕɫAµʙ
=6jYdar mRNA 7ĄƸ)Õɫµʙ>=þɈŮAƵɲ=Ȇȃ%ɫ
ƭAɞ!ʧǸưö-Ė)Ȓ>ħȀư) his3-ns mRNA3+ RNA14 mRNAA
ȂǵëǛƣAǝĹ*ȴƮhis3-ns mRNAö- RNA14 mRNA*	>7
xrn1Δ ħȀư)	$ Dom34 Aƾƅ=&ĶĹŮĥà=&Ƙ;)(!
(Fig. 1-13)!$Dom34:Hbs1ɣĂ°+jYdar mRNA* 3’¾;*
ÕɫAµʙ$	=&Ƙ;)(!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Dom34:Hbs1ɣĂ°& Ski7* CƦȟe|F+ NSD)	$Ȁ(=
ÂA=  
  
 >3%jYdar mRNA*Õɫ+ 3’Ʀȟ)ʜw]{* Aʠ­)IM
]]{*ƷŵĔĳ%= Ski7 ȴĂw]{*ɫʽAɞ
&%*Õɫ
µʙ>$	=&ɂ;>$(van Hoof et al., 2002)Dom34:Hbs1ɣĂ°& Ski7
* C Ʀȟe|F(CTD)*ƽɈ*ʝ	AƘ;)=Ȇȃ%ski7Δ ħȀư
ski7Δdom34Δ ħȀư) Ski7 * C Ʀȟe|F(CTD)ƾƅ^mOʅAȂǵ
his3-ns mRNAö- GFP-Rz mRNA*ëǛƣAǝĹ*ȴƮSki7* CƦȟe
|F(CTD)+ his3-ns mRNA*Õɫ+µʙ=(5.6 min and 4.4 min compared to 2.3 
min)GFP-Rz mRNA(2.5 min and 2.8 min compared to 2.9 min)*Õɫ+µʙ(	







˕−˘ ɂĿ  
 
Dom34:Hbs1ɣĂ°* No-Go Decay)=ÕĳƽɈ*ɫƭ  
 
 ƧȎȚ%+Dom34:Hbs1ɣĂ°NGD& NSD* 2"*ȳʊ)	$NGD*
5’¾ÖƑƑǬö-jYdar mRNA*Õɫ)ʱ$	=Ƙ;)=&A
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Figure 1-3. Ɂɱ&čʅȦǶƽƷ  
ȊƱǸǮ)	$mRNAčʅȦǶƽƷ mRNA*ȀőAɁɱȀő&$ɶʀ*
čʅȦǶAɞ!$	=&f[YħȀ´Ĵ mRNAÕɫȬ(nonsense-mediated decay̨
NMD) (Holbrook et al., 2004)8ȱǀSeAƾĭħȀȀő mRNAǯȀȃÕɫȬ%=
jYdar´ĴÕɫȬ(non stop decay˛NSD) (van Hoof et al., 2002)Ɂɱ«ʮʲļ)´Ĵ






Figure 1-4. NGD (No-Go Decay)*ƽƷ 
 ŋȃ(ƿƷʗAž" mRNA+Ɂɱ)´Ĵ mRNAÕĳÍÖƑˑ NGD: No-Go Decay˒
Aû=&Ȍ;>$	=(Doma and Parker, 2006Clement et al., 2006)*ÕĳƽƷ)













(a) ɁɱȱȴĔĳ&Ɂɱ«ʮĔĳ*ɣĂ°; aRF1·aEF1α·GTP(b) Pelota&Ɂɱ«ʮĔĳ*ɣ





Figure 1-6. ɁɱDYd):= NGD*ƺŘĖ 
ʘȶģĠŮDzjʣʡ×ɁɱDYdAřʇ(Dimitrova et al., 2009)*ʡ×
ʑ¿% mRNAÖƑ>=(Kuroha et al., 2010)3ʘȶģĠŮDzjʣʡ×):
=DYdǹǮ+ Not4A E3FRY&$rbD]{):<Õɫ>=(Dimitrova 











EPAɞ!Bot: anti-GFP Ż°%GIY^qabEPAɞ!(B) GFP-Rz 











Figure 1-8. Dom34:Hbs1 ɣĂ°+ȱǀSeAƾĭ mRNA *IM]]{):=Õɫ
Aµʙ= 
(A) DIG ƹʀ G1G2G3 rqAǺ	jVqabEPAɞ!āq
q+Ė)Ȓ GFP*ˆĞ)Ȉɡȃ%=ʡ×+ Table S2)3&6(B) Dom34ƾ











Figure 1-9. ȱǀSeAž"ɐȃ( mRNA*ĶĹŮ 






Figure 1-10. Dom34:Hbs1ɣĂ°+ 5’-NGDʰǹǮ*IM]]{):=ÕɫAµʙ= 
(A) Dom34:Hbs1 ɣĂ°+(G)-rich ʡ×*ÕĳÍÖƑAµʙ=Ė)Ȓ>ħȀư)
p416GPDp-GFP-(GGN)12-FLAG-HIS3rYzeAŃÈjVqabEPAɞ!








Figure 1-11. (G)-richʡ×+ʢǇ)	$ NGDAřʇ 
(A) W303ski2ΔħȀư) p416GPDp-GFP-X12-FLAG-HIS3AȂǵ=rYzeAŃÈ
ʻɗRNAUrAjVqabEP%ɫƭX+ĖȒDzjʣAȒ









Figure 1-12. GGNʘȶʡ×):<Ǹ=ÕĳÍÖƑ+Ɂɱ)´Ĵ= 
WO/MWze):<ɁɱA 10 Õʰʲļš (final concentration 100 ug/ml)
p416GAL1p-GFP-X12-FLAG-HIS3 rYze;*ʋÐALOdYAà=&%ɷ






Figure 1-13. Dom34:Hbs1ɣĂ°+jYdar mRNA*ÕɫAµʙ= 
ʧ Ǹ ư ö - Ė ) Ȓ  >  ħ Ȁ ư ) yCplac33GAL1p-HIS3-ns (his3-ns) (A) 3  +
p416GAL1p-RNA14 (RNA14-ns) (B)rYzeAŃÈFigure 1-9ĄƸ)ëǛƣAǝĹ





Figure 1-14. ½ǡw]{+jYdar mRNA*ƑǬçAřʇ 
(A) ʧǸưö-Ė)Ȓ>ħȀư) yCplac33GAL1p-HIS3 (pIT826) (HIS3) 3+
yCplac33GAL1p-HIS3-ns (pIT827) (his3-ns)rYzeAŃÈ6% TBE-Urea PAGEAǺ	
3’-UTR )ŀ=rq%jVqabEPAɞ! (B) dom34Δ ħȀư)
yCplac33GAL1p-HIS3-ns (pIT827) (his3-ns)rYzeAŃÈʻɗ+*ð* RNAU
r+ oligo dT (dT)AǺ	RNase H):=ÕɫAɞ!*š(A)ĄƸ)jV




qabEPAɞ!(D) ʧǸưö-Ė)Ȓ>ħȀư) yEplac195GAL1p-HIS3 
(WT)3+yEplac195GAL1p-HIS3-ns (NS)rYzeAŃÈ(A)ĄƸDIG ƹʀ
LNA-oligo dTrq%jVqabEPAɞ!jYdar mRNA* 3’Ʀȟ





Figure 1-15. x(A)ʬ*= his3-ns mRNA+ xrn1ƾƅ)	$ĶĹç= 
Top: HIS3ö- his3-ns mRNA*ƺŘĖĒɪJrcEPp{(ORF)AȒ
ȸˁɁɱˆĞAȒA*ʘȶ+x(A)ʡ×AȒRNase HÓǶ)Ǻ	JTA AS1 
(5'-ACGCACTCTCACTACGGTGATGAT-3’)%ȒBot: W303ö-Ė)Ȓ>ħȀư)
yCplac33GAL1p-HIS3 (pIT826) (HIS3) 3+yCplac33GAL1p-HIS3-ns (pIT827) (his3-ns)r







Figure 1-16. Dom34:Hbs1ɣĂ°+jYdar mRNA*ÕɫʰǹǮ*ķÉ(Õɫ)Ūɤ
%= 
ʧǸưö-Ė)Ȓ>ħȀư) yCplac33GAL1p-HIS3 (pIT826) (HIS3) 3+






Figure 1-17. Dom34:Hbs1ɣĂ°& Ski7* CƦȟe|F+ NSD)	$Ȁ(=ÂA
= 
Ski7* CƦȟe|F(CTD)+ his3-ns mRNA*Õɫ+µʙ=GFP-Rz mRNA*Õɫ















Figure 1-19. NGDNSD)= Dom34:Hbs1ɣĂ°*ÕĳƽƷ*}cĖ 
NGD)	$5’NGDʰǹǮ* 3’Ʀȟ3%Ɂɱw]{+ Dom34:Hbs1):<ɫ








Table 1-1  Yeast strains and plasmids used in this study 
 
 Strain/plasmids  Genotype[plasmid](plasmid number)    Source 
Strains 
W303-1a   MATa ade2 his3 leu2 trp1 ura3 can1    Lab stock 
YIT2013*  W303-1a ski2Δ::kanMX    Kuroha et al, 2010 
YIT2014*  W303-1a dom34Δ::hygMX   Kuroha et al, 2010 
YIT2015*  W303-1a hbs1Δ::natMX    Kuroha et al, 2010 
YIT2016*  W303-1a ski2Δ::kanMX dom34Δ::hygMX  Kuroha et al, 2010 
YIT2017*  W303-1a ski2Δ::kanMX hbs1Δ::natMX   Kuroha et al, 2010 
YIT2019*  W303-1a xrn1Δ::kanMX    Tsuboi et al., 2010 
YIT2020  W303-1a xrn1Δ::kanMX dom34Δ::hygMX  This study 
YIT2021  W303-1a xrn1Δ::kanMX hbs1Δ::natMX   This study 
YIT2022  W303-1a ski7Δ::natMX    This study 
YIT2023  W303-1a ski7Δ::hygMX dom34Δ::kanMX  This study 
 
plasmids  
p416GPDp  URA3 CEN      Mumberg et al. 1995 
p415GPDp  LEU2 CEN      Mumberg et al. 1995 
p415TEFp  LEU2 CEN      Mumberg et al. 1995 
p415ADHp  LEU2 CEN      Mumberg et al. 1995 
p414GPDp  TRP1 CEN      Mumberg et al. 1995 
p416GAL1p  URA3 CEN      Mumberg et al. 1994 
yEplac195  URA3 2mu     Gietz and Sugino, 1988 
pIT826  yCplac33GAL1p-FLAG-HIS3   Inada and Aiba, 2005 
pIT827  yCplac33GAL1p-FLAG-his3-ns   Inada and Aiba, 2005 
pSA144  p416GPDp-GFP-FLAG-HIS3    Dimitrova et al, 2009 
pIT2004  p416GPDp-GFP-R12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2007  p416GPD-GFP-F12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2008  p416GPD-GFP-E12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2009  p416GPD-GFP-L12-FLAG-HIS3   Dimitrova et al, 2009 
pIT2010  p416GPD-GFP-I12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2011  p416GPD-GFP-M12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2012  p416GPD-GFP-V12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2013  p416GPD-GFP-S12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2014  p416GPD-GFP-P12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2015  p416GPD-GFP-T12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2016  p416GPD-GFP-A12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2017  p416GPD-GFP-Y12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2018  p416GPD-GFP-H12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2019  p416GPD-GFP-N12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2020  p416GPD-GFP-D12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2021  p416GPD-GFP-C12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2022  p416GPD-GFP-W12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2023  p416GPD-GFP-Q12-FLAG-HIS3    Dimitrova et al, 2009 
pIT2024  p416GPD-GFP-G(Gly)12-FLAG-HIS3   Dimitrova et al, 2009 
pIT2025  p416GPD-GFP-W12-FS-FLAG-HIS3    Dimitrova et al, 2009 
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pIT2051   p416GPDp-GFP-K12(AAA)-FLAG-HIS3  Dimitrova et al, 2009 
pIT2052  p416GPDp-GFP-SL-FLAG-HIS3    Dimitrova et al, 2009 
pIT2090  p416GPDp-GFP-GNG12-FLAG-HIS3   This study 
pIT2091  p416GPDp-GFP-GUG12-FLAG-HIS3   This study 
pIT2092  p416GPDp-SL-GFP-GNG12-FLAG-HIS3   This study 
pIT2093  p416GPDp-SL-GFP-GUG12-FLAG-HIS3   This study 
pIT2094  p416GPDp-GFP-GGN6-FLAG-HIS3    This study 
pIT2095  p416GPDp-GFP-(G8A)2-FLAG-HIS3    This study 
pIT2096  p416GPDp-GFP-G12-FLAG-HIS3    This study 
pIT2097  p416GPDp-GFP-GGH12-FLAG-HIS3   This study 
pIT2098  p416GPDp-GFP-GGH10-FLAG-HIS3   This study 
pIT2099  p416GPDp-GFP-GGH8-FLAG-HIS3    This study 
pIT2100  p416GPDp-GFP-GGH6-FLAG-HIS3    This study 
pIT2101  p416GPDp-GFP-rare-FLAG-HIS3    This study 
pIT2102  p416GALp-GFP-GGN12-FLAG-HIS3    This study 
pIT2103  p416GALp-GFP-SL-FLAG-HIS3    This study 
pIT2104  p416GAL1p-GFP-FLAG-HIS3    This study 
pIT2105  p416GAL1p-GFP-Rz-FLAG-HIS3    This study 
pIT2106  yEPlac195GAL1p-FLAG-HIS3    This study 
pIT2107  yEPlac195GAL1p-FLAG-his3-ns    This study 
pIT2108  p416GPDp-GFP-Rz-FLAG-HIS3    Kobayashi et al., 2010 
pIT2109  p415GPDp-Dom34-FLAG LEU2 CEN   Kobayashi et al., 2010 
pIT2110  p415GPDp-Dom34-F47A-FLAG LEU2 CEN   Kobayashi et al., 2010 
pIT2111  p415GPDp-Dom34-D(47-60)-FLAG LEU2 CEN   Kobayashi et al., 2010  
pIT2112  p414GPDp-yhbs1-FLAG TRP1 CEN   Kobayashi et al., 2010 
pIT2113  p414GPDp-yhbs1-T232A-FLAG TRP1 CEN  Kobayashi et al., 2010 
pIT2114  p414GPDp-yhbs1-H255A-FLAG TRP1 CEN  Kobayashi et al., 2010 
pIT2115  p415GPDp-FLAG-Ski7 LEU2 CEN   This study 
pIT2116  p415TEFp-FLAG-Ski7 LEU2 CEN   This study 
pIT2117  p415ADHp-FLAG-Ski7 LEU2 CEN   This study 
pIT2118  p415GPDp-FLAG-Ski7-N LEU2 CEN   This study 
pIT2119  p415TEFp-FLAG-Ski7-N LEU2 CEN   This study 
pIT2120  p415ADHp-FLAG-Ski7-N LEU2 CEN   This study 
pIT2121  p415ADHp-FLAG-Ski7-C LEU2 CEN   This study 
pIT2122  p416GALp-GFP-rare-FLAG-HIS3    This study 
pIT2123  p416GALp-GFP-K12-FLAG-HIS3    This study 
pIT2124  p416GALp-RNA14     This study 




Table 1-2  List of oligonucleotides used for plasmid construction 
 
Gene Name     Primers for PCR 
 
GFP-GNG12-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 
 5’-GGACTAGTGTCCGCCACCTCCGCCACCTCCGCCACCTCCGCCACGCTAGTTTT 
 GTATAGTTCATCC-3’ 
GFP-GUG12-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and  
 5’-GGACTAGTGTCCACCACCACCACCACCACCACCACCTCCACCACGCTAGTTT 
 TGTATAGTTCATCC-3’ 
GFP-GGN12-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 
 5’-CTAGCGGTGGCGGAGGGGGTGGCGGAGGGGGTGGCGGAGGGA -3’  
GFP-GGN6-FLAG-HIS3 5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and  
 5’-GGACTAGTGCCACCCCCTCCGCCACCGCTAGTTTTGTATAGTTCATCC -3’ 
GFP-(G8A)2-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 
 5’-GGACTAGTTCCCCCCCCTCCCCCCCCGCTAGTTTTGTATAGTTCATCC -3’ 
GFP-G12-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’and  
 5’-GGACTAGTCCCCCCCCCCCCGCTAGTTTTGTATAGTTCATCC-3’ 
GFP-GGH12-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 
 5’-GGACTAGTTCCGCCACCTCCGCCACCTCCGCCACCTCCGCCACCGCTAGTTTT 
 GTATAGTTCATCC -3’ 
GFP-GGH10-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 
 5’-GGACTAGTACCTCCGCCACCTCCGCCACCTCCGCCACCGCTAGTTTTGTATAG 
 TTCATC -3’ 
GFP-GGH8-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 
 5’-GGACTAGTGCCACCTCCGCCACCTCCGCCACCGCTAGTTTTGTATAGTTCATC 
 C -3’  
GFP-GGH6-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 




Table 1-3  List of oligonucleotides used for DIG labeled probe 
 
Probe Name        DIG-label method  oligonucleotide sequences 
 
GFP  Internal label (PCR) 5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and  
    5’-GGACTAGTTTTGTATAGTTCATCCATGCCA-3’ 
G1 (GFP 1-75)  5’ end label 5’-CCCATTAACATCACCATCTAATTCAACAAGAATTGGGAC 
    AACTCCAGTGAAAAGTTCTTCTCCTTTACTC-3’ 
G2 (GFP 321-385) 5’ end label 5’-CAATACCTTTTAACTCGATACGATTAACAAGGGTATCAC 
    CTTCAAACTTGACTTCAGCACGCGTC-3’ 
G3 (GFP 654-714) 5’ end label 5’-TTTGTATAGTTCATCCATGCCATGTGTAATCCCAGCAGC 
    AGTTACAAACTCAAGAAGGACC-3’ 
3’UTR (HIS3)  Internal label (PCR) 5’-CGGGATCCTAGTGACACCGATTATTTAAAGCTGC-3’ and  
    5’-GGAATTCCTCGTTCAGAATGACACGTA-3’ 
ORF (HIS3)  Internal label (PCR) 5’-GCTCTAGAGTCACTGCCAGGTATCGTT-3’ and  
    5’-CGGGATCCCATAAGAACACCTTTGGTGGAGG-3’ 
NS1 (-52~+20 of stop codon) 5’ end label 5’-CTTACTGACATTCATAGGTATACATATATACACATGTAT 
    ATATATCGTATGCTGCAGC-3’ 
NS2 (+21~+79 of stop codon) 5’ end label 5’-TTTAAATAATCGGTGTCACTGGATCCCATAAGAACACCT 
    TTGGTGGAGGGAACATCGTTGGTACCATTGG-3’ 
NS3 (+80+149 of stop codon) 5’ end label 5’-CGTTCAGAATGACACGTATAGAATGATGCATTACCTTGT 
    CATCTTCAGTATCATACTGTTCGTATACATA-3’ 
LNA-dT  5’ end label 5’-tTtTtTtTtTtTtTtTtTtTt-3’ (LNA is indicated by upper case) 
RNA14  Internal label (PCR) 5’-CGGGATCCATGTCCAGCTCTACGACTCCTGATTTAC-3’ and  
   5’-CCATCGATGATCCGAATTTTCAGATATATACATTGAATA 
    ATCGTACCA-3’ 
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˖−˕ ɤƖ  
 
 mRNA *ƿƷʗ8ʘȶDSeʘȶģĠŮDzjʣʡ× mRNA
čʅȦǶƽƷ*"%= NGDˑ No-Go Decay A˒řʇ&ġĉ>$
ƧȎȚ%+Ƞ˖ȞDom34:Hbs1ɣĂ°* No-Go Decay)=ÕĳƽɈ*ɫƭ*ʛ

















3’Ʀȟ%ÕĳÍÖƑʇ<50-140 nt ʮ* mRNA ƑǬǸ=&AɥÔ
* RNAƑǬA RNA-seqǏ):<ĄĹţ;>WQYůġAɫƭȴƮ









˖−˖ ŕɽ  
 
˕˒ NGD (No-Go Decay) Aû=ȯɇÍ  mRNA 
 
 Ǹȯɇ+Ȁő(^mOʅAȂǵ=þɈŮ*= mRNA Aʵô=čʅȦǶƽ
ƷAž"f[YħȀ´Ĵ mRNA ÕɫƽƷ (NMD; Nonsense-Mediated mRNA 
Decay) +ƥŵǩȱǀSe (PTC; premature termination codon) Až" mRNAAÕɫ
=jYdarmRNAÕɫƽƷ (NSD; Non-Stop Decay) +) ORF (open reading 
frame) Í%*x(A)ʬ¥à):<Ǹ=jYdar mRNA *ÕɫAɞ
3
No-Go Decay (NGD)+ ORF%w]{½ǡ=&AɶʀÕĳÍÖƑAɞ
	jYdar mRNA AǸ=&%* mRNA *ÕɫAµʙ=(Doma and 
Parker, 2006; Passos et al., 2009)ƧȎȚ*Ƞ˖Ȟ:< Dom34:Hbs1ɣĂ° mRNA*
3’Ʀȟ;w]{Aɫʽ=&%jYdar mRNA *ÕɫAµʙ$	=
&AƘ;)(Tsuboi et al., 2012)NGD+ mRNA*ĶĹ(ƿƷʗ8ɉr
ç mRNAʘȶDSeǁ)ɕʾƒǸxur`eʬ):<Ǹ
=&Ƙ;)(!$	=(Doma and Parker, 2006; Chen et al., 2010; Kuroha et al., 
2010; van den Elzen et al., 2010; Tsuboi et al., 2012)(;*IehO
D\ö-ȯɇÍ*ƹȃ mRNA*ĄĹ)+ɍ!$	(	 
 
˖˒ ʡ×ǯȀȃ mRNAÕɫȬ  
 
 3%ɐȃ( mRNA*Õɫ)"	$Ȱ¢$¤)7 mRNA)ǯȀȃ
)Ĵę=ʡ×* mRNA*ÕɫAµʙ=&ġĉ>$	=c-fos mRNA
ˑGrosset et al., 2000 ˒α-globin RNAˑWaggoner and Liebhaber, 2003 ˒Puf (Pumilio 
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Family)ȴĂʡ×Až" mRNAˑ Spassov and Jurecic, 2003 ˒AU-richʡ×Až" mRNA
ˑVasudevan and Peltz, 2001; Vasudevan et al., 2005˒Ȣġĉ>$	= 
 
˗˒ CBP1 (Cytochrome B mRNA processing)*ȯɇÍ)=ƽɈ  
 
 CBP1ʟªĳ)+ ORF)7x(A)ʬ¥àWPfĴęʕő* mRNA)à
ORF;x(A)ʬ¥à>jYdar mRNAAȂǵ=&Ȍ;>
$	=(Sparks et al., 1997)*jYdar mRNA+ NSD):<Õɫµʙ>=
&ġĉ>$	=(Frischmeyer et al., 2002)3ǥȮǞAP[Ʃ¨
(@ ƢƽċĈƩ¨)ħƠ=&%ǁő( CBP1 mRNA&ǈ0jYda
r mRNA*Ȃǵʨĥà=&ġĉ>$	=(Sparks et al., 1998)(
;jYdar mRNA *Ȃǵʨĥà=&*ǸǶĵȃűȿ+Ƙ;)(!$
	(	ƓCBP1 ^mOʅ+Ʊ)Se>=zdSeD^mOʅ%z
dSeDÍ)	$ƽɈAž"CBP1^mOʅ+ COB (Cyotocrome B) mRNA
* 5'-UTR (5’-untranslated region) ȴĂ*ʋÐšÚŤö-ɁɱÚŤAɞ
&
Ƙ;)>$	=(Sparks et al., 1997; Islas-Osuna et al., 2002) 
 
˘˒ tRNAYrFWPIehOD\ SENɣĂ°  
 
 tRNAYrFWPIehOD\SENɣĂ°+ÔɔʢǇ)	$zdS
eD)ňę tRNA *YrFWPAɞ!$	=&ɂ;>$	=(Yoshihisa 
et al., 2003; Yoshihisa et al., 2007)Ɠ%ãǮȯɇ)	$ SENɣĂ°+Ʊ)ňę
$	=ÔɔʢǇ)	$ SEN ɣĂ°+zdSeDɠŉ% tRNA *YrF
WPAɞ
&Ƙ;)(!$	=Ʊ)ŜÚȃ)ňę SEN ɣĂ°+
tRNA *YrFWP)êÕ(ÂAȒ&ġĉ>$	=(Yoshihisa et al., 
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2007; Dhungel et al., 2012)(;SENɣĂ°*zdSeD/*ňę*Ǹ
Ƕĵȃ(űȿ+Ƙ;)(!$	(	3nd)	$+ SEN ^mOʅ
(TSEN54, TSEN2, TSEN34)*ȀőɊƼńɊŞŵÉAřʇ&Ȍ;>$	
=(Budde et al., 2008) 
 
˙˒ ƧȎȚ*Ȇȃ  
 















˖−˗ ȴƮ  
 
CBP1 mRNA+ȯɇÍ)	$ÕĳÍÖƑAû=  
 
 ƧȎȚ*Ƞ˖Ȟ:< Dom34:Hbs1 ɣĂ°jYdar mRNA * 3’Ʀȟ3%Ɂɱ
½ǡw]{Aɫʽ=&%* mRNA AĶĹç=&AƘ;)
ˑTsuboi et al., 2012 ˒*ɫƭ*ʛȖ%x(A)ʬ ORF)¥à>= mRNA
&$>3%ɫƭɞ@>$ CBP1 mRNA)"	$ɫƭAɞ!ˑ Sparks et al., 
1997 ˒CBP1+zdSeDydaOY)	$WdO{ B*ʋÐšÚŤ
ǯ) pre-mRNA *ÖƑ&*Ɂɱ)ʱ=&Ƙ;)(!$	=ˑSparks et 
al.,1997; Islas-Osuna et al., 2002 ˒CBP1 mRNA7>3%ŶƘ;)$:

)dom34Δ ħȀư)	$jYdar mRNA ĶĹç=&ȑɶ>
ˑFig. 2-1A, B ˒GAL1r}^;* CBP1ʟªĳ*ʋÐAW~adJpȳ
ƚȃ)UrPjVqabEPAɞ	Ĺʨ=&%ëǛƣAǝĹ
*ȴƮxrn1Δ ħȀư)ǈ0xrn1Δdom34Δ ħȀư)	$jYdar
mRNA*ëǛƣ 12.2Õ; 19.2Õ)ĥàˑFig. 2-1A, B˒(;ˍ
0&)>3%Ƙ;)>$	 ORF:<x(A)ʬ¥à>$Ǹ
=jYdar mRNA)à22.6Õ; 32Õ§/īëǛƣĥà=ʋÐ
ǹǮɩĿ>ˑFig. 2-1A, B ˒3*ʋÐǹǮ+ ski2ΔħȀư%7ɩĿ>
















ˑTsuboi et al., 2012˒&Ɏ=3’¾;*ÕɫǸ(	W303ski2ΔħȀư)
	$ 5’¾ÖƑǬƵÔ>35’¾;*ÕɫǸ(	 W303xrn1Δ ħȀư)
	$ 3’¾;*ÖƑƵÔ>=&;7*ȴƮ+ƈž>=ˑFig. 2-1B, 
2-2A ˒ 
 






&ÕĳÍÖƑ+ɩĿ>((!ˑFig. 2-2A top ˒;)>>*ƾ
ĭˆĞAȯÕçĄƸ*ɫƭAɞ!ȴƮ652-726nt*ʡ×Aƾĭ=&%Ö
ƑǬǸ((=&;ÕĳÍÖƑ)+652-726nt*ʡ×Ūɤ%=&Ƙ
;)(!ˑ Fig. 2-2A bottom, 2-3A ˒¡š*ʡ×AECIS (Endonucleolytic Cleavage 
Inducible Sequence)&ċ.>3%NGD*ɫƭ):<ORFÍ%*ÕĳÍÖƑ+ORF
%Ƹ(ʡ×):<w]{½ǡ=&%*w]{*5’¾%ÖƑ

















&Ƙ;)(!ˑFig. 2-2C, 2-3B ˒%ÕĳÍÖƑ)ECIS*ƿƷʗŪ





)ħȀAŃÈ*ÕĳÍÖƑAjVqabEP%ȑɶˑ Fig. 2-2E ˒






Structure mutant 1*x^mRNAAƂȶFig. 2-1BĄƸ)ɻ0ȴƮW303 













zdSeDňęçWPfö- ECIS*Ɂɱ CBP1 mRNA*Õ
ĳÍÖƑ)+Ū˅%=  
 
 >3%Ƙ;)(!$	= NGD *ÕĳÍÖƑ*ƽƷ)+ÕĳÍÖƑ) ORF
w]{DYdʡ×*ɁɱŪɤ%!3ȯɇʅ)=YrFW
P&$Ȍ;>$	=ńɇ°ɋ%* IRE1 ):= Hac1 mRNA *ÕĳÍÖƑ)7
ORF %*w]{*ɁɱDYdŪɤ%=&Ƙ;)(!$	=







 ƿ)Yb{rƷʗA ORF *ȇÛ)ſÈɁɱAʲļ&?8+<
ÕĳÍÖƑ+ʲļ>(Fig. 2-4B left panel, 2-3C)ÕĳÍÖƑ)Ūɤ( mRNA*
ʡ×AĄĹ=Ȇȃ%zdSeDňęçWPfˑMTS ˒uORF *ƾƅ=









ɱAźÚx^mRNA A±ŵĺˌAɞ!3>;* mRNA +
ʮ	 3’-UTRAž NMDAû=þɈŮ=6NMDAʲļ= upf1ΔħȀ
ư)"	$7ĄƸ)ɫƭAɞ!*ȴƮECIS AɁɱ(	x^mRNA




CBP1 * MTS & ECIS ʡ×AſÈx^mRNA +ÕĳÍÖ
ƑAû=  
 
# 1$zdSeDňęçWPfˑMTS 0˒ ECIS (8)*,
21/&7'86'1,7-5$MTS0ECIS 8+-EBG>GmRNA8
+-%CBP1 mRNA* 643 - 738 nt* ECISAć5ʡ×AGFP&HIS3ʟªĳ*ʰ)ſ
ÈMTS A N Ʀȟ)ſÈ(MTS-GFP-ECIS-HIS3)x^mRNA A±ŵ
(Fig. 2-4A)3*x^mRNA)Ƹ(ħȀAŃÈ=&% CBP1 mRNA
ĄƸ)ɫƭAɞ!DIGƹʀ GFPö- HIS3 probeAǺ	jVqab
EPAɞ	ÖƑâǴ (=cleavage product/(full length transcript+ cleavage product)) A
ȥÔ*ȴƮECISʡ×Až"x^)MTSAſÈ=&%*â
Ǵ 5’¾)	$ 12.6%; 35.8%/3’¾)	$ 17.0%; 40.3%)ĥà=&
Ƙ;)(!(Fig. 2-5B lane 5-8)3ECISʡ×*4Až"x^mRNA(5’
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¾: 12.6%3’¾: 17.0%)&Sd*x^mRNA(5’¾: 9.2%3’¾: 11.0%)
Aǈ0=&%MTS Až(	ĢĂ)	$7ÕĳÍÖƑřʇ>$	=
&Ƙ;)(!(Fig. 2-5B lane 1, 2, 5, 6);)ECIS)p{WpdħȀ
AſÈ=&ÕĳÍÖƑ*âǴ@)ǛŅ3ECIS *ƿƷʗú>
(	ħȀ(Structure mutant 1)ʡ×AſÈ=&ÕĳÍÖƑɩĿ>((=&
CBP1 mRNAĄƸ)ɩĿ>(Fig. 2-5B lane 9-12);) ECISȇÛ)ȱǀSeA
ſÈɁɱAźÚƚ*ÖƑâǴ+ɘǛŅ(Fig. 2-5B lane 13-16)
(;*ÖƑâǴ+ ECIS *4Až"7*&12Ȣ(!(Fig. 2-5B lane 
13-16)ECIS ʡ×ȇÛ)ȱǀSeAſÈ mRNA +ʮ	 3’-UTR Až"6






Y)ňę=^mOʅ* NƦȟ 100 aa)ȼƄ*ȴƮ GCV1ö-MSS116












tRNAYrFWPIehOD\ SENɣĂ° CBP1 mRNA
AÕĳÍÖƑ=  
 
 ȯɇʅ)= mRNA*ÕĳÍÖƑ+ Ire1):= XBP1 mRNA*YrFWP










>((!(Fig. 2-6A lane 3, 4)(@ SENɣĂ° CBP1 mRNA*ÕĳÍÖ
ƑAɞ!$	=&Ȓď> 
 3SENɣĂ°*zdSeD/*ňę)ƾƅAȒ SEN54* 200-232 aaA
ƾƅưAǺ	$ɫƭAɞ!jVqabEP*ȴƮSEN54* 200-232 
aaAƾƅư)	$ÕĳÍÖƑɩĿ>((!&;(Fig. 2-6B lane 4)
SEN ɣĂ°*zdSeD/*ňęÕĳÍÖƑ)Ū˅%=&Ƙ;)(















>(!(Fig. 2-7B)(@ >3%ġĉ>$ NGD *^Rad
mRNA+ SENɣĂ°):=ÕĳÍÖƑAû(	&Ƙ;)(! 
 ;) SEN ɣĂ°)"	$ɵȯ(ɫƭAɞ
6ɳˌȦÍ tRNA YrFW
Pɫƭ (Trotta et al., 1997; Trotta et al., 2006)Aɞ!ȯɇżÔǗ; FLAG-Sen2-WT
3+5’IehOD\ǓŮ)ƾƅAȒ FLAG-Sen2-His297Ala ):< SEN
ɣĂ°AȪɢɫƭAɞ!(Fig. 2-8)3Ġʅ&$ 32P-UTP ƹʀ RNA A
Ǻ	*ȴƮƹʀ)Ǻ	 ECISAć5 RNA; 41ntʮ*ƑǬÖ<Ô>




<Ȫɢ SEN ɣĂ°):=ɳˌȦÍ tRNA YrFWPɫƭ%+ɩĿ>(
(!(Fig. 2-6D lane 8, 12, 16)*ȴƮ+ SENɣĂ°ȇƂ CBP1 mRNA*ÕĳÍ
ÖƑAɞ!$	=&AȒď$	=ɏĊǘ	&)Sen2-His297Ala):<ËȪ
ɢ> SENɣĂ°+ CBP1 mRNA* 3’*IehOD\ǓŮ)ƾƅAȒ
>3% Sen2-His297Ala ):<ËȪɢ> SEN ɣĂ°+ tRNA *YrFWP
)	$ 5’¾ÖƑǦ*ÕĳÍÖƑAɞ
&Ȓ>$<ˑTrotta et al., 2006˒











Ŷ+W303xrn1Δö-W303xrn1Δdom34Δ ħȀư; RNAAżÔ30-150 nt
* RNAƑǬ)"	$ Hiseq2000 (illumina)%ɫƭAɞ! (Fig. 2-9A, RNA-seq+ƫ
īĵɖʧʩƤȎȚĻ):=)ƫīĵɖʧʩƤȎȚĻ):<*ńƑǬAÔɔʢ
Ǉ*Rj{ DNA)DF|d$		ńƑǬ*eƍ 100Aʈ=
ʟªĳ)"	$ɩĿ>=ƑǬʨ*ǈ(= reads in xrn1Δdom34Δ / reads in xrn1Δ)Aȥ
Ô*­ʟªĳȾ)"	$ƳPp)3&6(Fig. 2-9B)jYdar mRNA
+ dom34Δ ħȀư)	$ 3’Ʀȟ*ńƑǬAǸ=&;Rj{)Ĵę=Þ
Ă+ 15%%=ńƑǬ*ƑǬƍ 100Aʈ=ʟªĳ)"	$+ 20%*ÞĂ%ɩ
Ŀ>CBP1, AEP2, RNA14ö- SIR1+jYdar mRNAAǸ=&ġĉ
>$	=(Sparks et al., 1998)Fig. 2-9C)Ȓ:
)>;* mRNA* ORF*
x(A)ʬ¥à­ȼ)ń(ƑǬəȘ$	=&ɩĿ>ƓjYd
ar mRNA *ɩĿ>=ƑǬʨ*ǈ+­*ʟªĳȾ)	$7: 20%Ȗ
Ŗ%=&;jYdar mRNA * xrn1Δdom34Δ ħȀư%Ǹ=ƑǬʨ+
xrn1ΔħȀư)ǈ0$ɘĩ	@%+(	&ɂ;>=ƿ)ɩĿ>=ƑǬʨ
*ǈ*­ʟªĳȾ% 20%*ÞĂAȒzdSeD)ňę=^mOʅAS
e= mRNA)"	$ɵȯ(ɫƭAɞ!(Fig. 2-9B, Table2-4)ǸçĵȃŸǏ)Ġ
#	Rj{Fe(zdSeD)ňę=mRNA*ɫƭ(Mark et al., 2001) :







> (Fig. 2-9D)*ȴƮ+	"*zdSeD)ňę= mRNAÕĳÍ
ÖƑAû=&AȒď$	=>;* mRNA+ SENɣĂ°%(zd
SeD)ňę=	"*IehOD\ (RMP1, PNPase and etc.)(')





˖−˘ ɂĿ  
 
CBP1 mRNA+ tRNAYrFWPIehOD\ SENɣĂ
°):=ÕĳÍÖƑAû=  
 
 ƧȎȚ)	$tRNA YrFWPIehOD\ SEN ɣĂ° CBP1 
mRNA *ÕĳÍÖƑAzdSeD%ɞ!$	=&AƘ;)CBP1 
mRNAǸȯɇÍ)	$ÕĳÍÖƑAû=&AȂɥ(Fig. 2-1)mRNAˆĞ
ƾĭư*ɫƭ):<zdSeDňęçWPf(MTS)ö-652 - 726 nt*ƿ
ƷʗAŞŵ= ECISʡ×(Endonucleolytic cleavage inducible sequence)ÕĳÍÖƑ)
+Ūɤ%=&AƘ;)(Fig. 2-2, 3)MTS& ECIS*ɁɱźÚÕĳÍÖƑ

























 >3%* NGD (No-Go Decay)*}c)	$+w]{ ORF%DY
d*ȴƮ&$ÕĳÍÖƑřʇ>=&ġĉ>$	=(Doma and 










ƓtRNA*ĢĂSENɣĂ°):<ÖƑAûš* tRNA+ TRL1 (RLG1)










= mRNA%=&ġĉ>$	=(Saint-Georges et al., 2008)mRNA*Ɂɱ+
*čʅȦǶ)ʦɤ%=&Aʒ*ňę)7ş˂A=&ġĉ
>$<(Mark et al., 2002; Garcia et al., 2007; Saint-Georges et al., 2008; Eliyahu et al., 





















(Yoshihisa et al., 2007; Dhungel et al., 2012)!$SENɣĂ°*zdSe
D/*ňę*ǸǶĵȃ(űȿ+ CBP1 mRNA *ÕĳÍÖƑAɞ
&%=þɈŮ
=3ãǮȯɇ)	$ SEN ɣĂ°+Ʊ)ňę$<3SEN ^
mOʅ(TSEN54, TSEN2, TSEN34)*Ȁő+nd)	$ɊƼńɊŞŵÉAřʇ
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 SC ğĚ: yeast nitrogen base without amino acids 6.7g/l, DzjʣǙĂǮ 1.3g/l, 2% 
glucose 




 ƧȎȚȠ˕Ȟ%+ Table 1-1 )ȒrYzeAǺ	$ĺˌAɞ!3*
SYdOW)Ǻ	JT+ Table 1-2)3&6ƧȎȚȠ˖Ȟ%+ Table 
2-1 )ȒrYzeAǺ	$ĺˌAɞ!3*SYdOW)Ǻ	









˗−˖ ƓǏ  
 
RNA *żÔ  
 
 Ȇȃ*ư)=yK*DzjʣAʵ	 SC Ǘ°ğĚ)ƴɗ30℃%
OD600=0.6 3%ğˋšğˋǗ 20ml AʞũÕʽ(3500rpm×5min RT) :<ʻɗ
>A RNA buffer 400μl)ŴǢRNAǺpHj 400μl Aà65℃% 5
Õʰˀȼš5ÕǋÑʞũÕʽ(13000rpm×5min RT)ǚ)ŀ$ĄƸ
*Ɔ±ApHjpHj˔Ov{PCIˑ pHjOv{
F]DzDSʨǈ 25: 24: 1*ǙĂǮ˒ %ɞ	RNA*żÔȪɢAɞ!
ǚ)"	$I^jǎǆAɞ	ţ;>uad) DEPC ÓǶǊ 50μl A
à RNAɳƐ& 




 ɯ%±ŵ RNAɳƐA nanodrop(nanodrop)% RNAǣŖAǝĹšRNA 0.6μg
A RNA sample buffer 21.5μl)à65℃% 5minàǪǋ%ŭÑ>Av
{Dcne-MOPS 1.2% DLYR)DrFʾǉǑãAɞ!Ǒãš
20×SSC AǺ	M~oqabEPǏ):< RNA A|q)ʋÐ
UV crosslinker(GE sYQD) :< RNAAėĹDigoxigenin(DIG)-11-dUTP
%ƹʀȆȃ* RNA*rqAǺ	$ 50℃%ƛkFq_F\WA
ɞ!ƧȎȚ%Ǻ	DIGrq+Table S3)3&6|qAwash buffer 
1, 2%ǒǕšyFʣlapC)Őʤ Blocking Reagent%qaM
PAɞ	Ż DIG-APŻ°&øūWash buffer 3%|qAǒǕwash 
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buffer 4%|qAŒɟçCDP-Star detection kit%øūšLAS-3000 
mini(FUJIFILM)AǺ	$ƵÔAɞ!ƱUr*Ĺʨ+ƹǟƟȸA±ŵ>
&ǈʍ=&):<ɞ! 
 RNA sample buffer: 50% formamide, 5mM NaOAc, 1mM EDTA 20mM MOPS, 6% 
formaldehyde, 5% glycerol, 0.1mg/ml Bromophenol Blue, 0.1mg/ml xylene cyanol 
 10×MOPS buffer(pH7.0): 0.2M MOPS, 50mM NaOAc, 10mM EDTA 
 20×SSC: 3M Nacl, 0.3M sodium citrate 
 hybridization solution: Roche 
 wash buffer 1: 2×SSC, 0.1% SDS 
 wash buffer 2: 0.1×SSC, 0.1% SDS 
 wash buffer 3: 0.1M maleic acid, 0.3% Tween-20 
 wash buffer 4: 0.1M Tris-HCl(pH9.5), 0.1M NaCl 
 Hybond-N+ membrane: Amersham 
 Anti-digoxigenin-AP: Roche 
 DIG-DNA labeling Kit: Roche 





30℃% OD600=0.63%ğˋšğˋǗ 20mlAʞũÕʽ(3500rpm×5min RT) :<
ʻɗ*šǗ°ğĚAú<ʵPSY SC Ǘ°ğĚ)ŴǢāɰĹ







 Ȇȃ*ư)=yK*DzjʣAʵ	 SC Ǘ°ğĚ)ƴɗ30℃%
OD600=0.6 3%ğˋšğˋǗ 20ml AʞũÕʽ(3500rpm×5min RT) :<ʻɗ
>A TCA buffer 500μl )ŴǢ20% TCA 500μl& 0.5mm Zircunia/ Silica Beads 
500μlAàwbaOYǚA&<ʞũÕʽ(13000rpm 10min 4℃)Aɞ!
ǎǆA SDS Sample buffer 300μl)Ǡ100℃% 5ÕʰàǪ>AÎŖʞ
ũÕʽ(13000rpm 10min RT)Aɞ	ú<ÔǚA^mOʅɳƐ& 
 TCA buffer: 20mM Tris-HCl(pH6.8), 50mM NH4OAC, 200mM EDTA, 1mM pmsf 
 SDS Sample buffer: 7% SDS, 30% glycerol, 200mM Tris base, 20mM EDTA, 1M DTT, 




 ɯ%±ŵ^mOʅɳƐ 10μlA 15% SDS-PAGE%ʾǉǑãǑãš
RA Cathode buffer%ŒɟçPVDF|qA|^j%ǒǕAnode 
buffer 2%Œɟçš|q)ÆȖ*RA electro-blotting):<^mOʅAʋ
ÐʋÐš|qA PBS/0.1% Tween-20)ǠYM{zO%q
aMPAɞ	ƿŻ°øū(Ż FLAG Ż°)Aɞ!|qA PBS/0.1% 
Tween-20%ǒǕš;)ƿŻ°øū(Ż mouseŻ°)Aɞ!*šLumi-Light 
Western Blotting Substrate%|qAøūšLAS-3000 mini(FUJIFILM)A
Ǻ	$ƵÔAɞ! 
 Anode buffer 2: 20% methanol, 25mM Tris-HCl(pH10.4) 
 Cathode buffer: 0.04M Glycine, 20% methanol, 25mM Tris-HCl(ph9.4) 
 PVDV membrane: Amersham 
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 Ż FLAGŻ°: Monoclonal Anti-FLAG(SIGMA) 
 Ż mouseŻ°: Anti-rabbit Ig horseradish peroxidase linked-whole antibody(from donkey) 
(Amersham) 
 PBS/0.1% Tween-20: 10mM Na2HPO4/NaH2PO4(pH7.5), 0.9% NaCl, 0.1% Tween-20 




 Ȇȃ*ư)=yK*DzjʣAʵ	 SC Ǘ°ğĚ)ƴɗ30℃%
OD600=0.83%ğˋšğˋǗ 800mlAʞũÕʽ(3500rpm×5min RT) :<ʻɗ
Ǘ°ȜȮAǺ	$ÒȴÒȴɗAƳ&ʪAǺ	$Ǘ°ȜȮ%Ȑȏ
lysis buffer 2.5ml)ǠɫšʞũÕʽ(3500rpm×10min 4℃)%ǠŮǾÕAǎǆ
*ǚAȯɇȩżÔǗ&żÔȯɇȩżÔǗ 800μlA Gradient master(BIO 
COMP) :<±ŵ 10-50%YOYǠǗ)ʦŉ>A 10-50%YOY
ľŖæʡʞũ(27000rpm×3h 4℃)):<ÕʽBIO-MINI UV MONITOR(ATTO)%
A260*ǝĹ-) Position Gradient Fractionator(TOWA LABO)%x]{*ÕǾA
ɞ!WȫľŖæʡʞũǏš)ÕǾāUrA RNA żÔ=ʹ+U
r 224μl) 8MPDgXģʣ 500μl& 100% I^j 750μlAàwba
OYAɞ	ʞũÕʽ(13000rpm×15min 4℃)Aɞ!ÕʽǚAú<ʵI
^jǎǆAɞ	ǎǆA DEPCÓǶǊ 30μl)ŴǢRNAɳƐ& 
 lysis buffer: 20mM HEPES(pH7.4), 2mM Mg(OAc)2, 100mM KOAC, 0.5 mM DTT, 1mM 
PMSF, Complete mini EDTA-free 1tablet/10 ml 
 10% sucrose solution: 10% sucrose, 10mM Tris, 70mM NH4OAC, 4mM Mg(OAC)2 






 Ȇȃ*ư)=yK*DzjʣAʵ	 SC Ǘ°ğĚ)ƴɗ30℃%
OD600=0.8 3%ğˋšğˋǗ 800ml AʞũÕʽ(3500rpm×5min RT) ):<ʻɗ
Ǘ°ȜȮAǺ	$ÒȴÒȴɗAƳ&ʪAǺ	$Ǘ°ȜȮ%Ȑȏ
lysis buffer 2.5ml)ǠɫšʞũÕʽ(3500rpm×10min 4℃) %ǠŮǾÕAǎǆ
*ǚAȯɇȩżÔǗ&żÔȯɇȩżÔǗ 200μl A Binding buffer 
200μl&ǙĂanti-FLAG M2 resin(sigma) 400μl&FMtd(2hour, 4℃)
IXA-100 buffer% 3ēǒ	IXA-100 buffer& 0.6mg/ml FLAG peptide%ǠÔ(30min, 
4℃)ÇȁǎʳǏš*āUr* RNA żÔ=ʹ+RNA*żÔ*˄&ĄƸ)ɞ
! 
 lysis buffer: 20mM HEPES(pH7.4), 2mM Mg(OAc)2,100mM KOAC, 0.5 mM DTT,1mM 
PMSF, Complete mini EDTA-free 1tablet/10 ml 
 Binding buffer: 100mM Tris-HCl pH7.5, 200mM KCl, 24mM Mg(OAc)2, 1.5mM DTT, 
1mM PMSF, Complete mini EDTA-free 1tablet/10 ml, RNase inhibitor 50u/10ml 
 IXA-100 buffer: 50mM Tris-HCl pH7.5, 100mM KCl, 12mM Mg(OAc)2, 1mM DTT, 
1mM PMSF, Complete mini EDTA-free 1tablet/10 ml 
 
RNaseH):= RNAÖƑ  
 
10µg* RNA& 300ng*JTAYoelM{%ǫu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* 1×Hyb Mix)ɜɫ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RNAƑǬ 30-150 nt*ʮ* DNA






˗−˗ Əǲ  
 
Gietz, R.D. and Sugino, A. (1988). New yeast-Escherichia coli shuttle vectors constructed 
with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene 74, 
527-534. 
 
Goldstein, A.L., and McCusker, J.H. (1999). Three new dominant drug resistance cassettes 
for gene disruption in Saccharomyces cerevisiae. Yeast 15, 1541-1553. 
 
Mumberg, D., R. Muller, and M. Funk. (1995). Yeast vectors for the controlled expression of 
heterologous proteins in different genetic backgrounds. Gene 156, 119-122. 
 
Mumberg, D., R. Muller, and M. Funk. (1994). Regulatable promoters of Saccharomyces 
cerevisiae: comparison of transcriptional activity and their use for heterologous expression. 
Nucleic Acids Res 22, 5767-5768. 
 
Sakumoto, N., Mukai, Y., Uchida, K., Kouchi, T., Kuwajima, J., Nakagawa, Y., Sugioka, S., 
Yamamoto, E., Furuyama, T., Mizubuchi, H., et al. (1999). A series of protein phosphatase 
gene disruptants in Saccharomyces cerevisiae. Yeast 15, 1669-1679. 
 
Sambrook, J., and Russell, D. W. (2006). The condensed protocols from Molecular cloning:A 
Laboratory Manual, Third ed. Ed., Third ed. Ed., Cold Spring Harbor Laboratory Press, Cold 
Spring Harbor, New York 
 
Wach, A., Brachat, A., Pohlmann, R., and Philippsen, P. (1994). New heterologous modules 
 
 132 
















































Dom34:Hbs1 Plays a General Role in Quality-
Control Systems by Dissociation of a Stalled
Ribosome at the 30 End of Aberrant mRNA
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Translation arrest leads to an endonucleolytic
cleavage of mRNA that is termed no-go decay
(NGD). It has been reported that the Dom34:Hbs1
complex stimulates this endonucleolytic cleavage
of mRNA induced by translation arrest in vivo and
dissociates subunits of a stalled ribosome in vitro.
Here we report that Dom34:Hbs1 dissociates the
subunits of a ribosome that is stalled at the 30 end
of mRNA in vivo, and has a crucial role in both NGD
and nonstop decay. Dom34:Hbs1-mediated dissoci-
ation of a ribosome that is stalled at the 30 end of
mRNA is required for degradation of a 50-NGD inter-
mediate. Dom34:Hbs1 facilitates the decay of
nonstop mRNAs from the 30 end by exosomes and
is required for the complete degradation of nonstop
mRNA decay intermediates. We propose that
Dom34:Hbs1 stimulates degradation of the 50-NGD
intermediate and of nonstop mRNA by dissociating
the ribosome that is stalled at the 30 end of themRNA.
INTRODUCTION
No-go decay (NGD) of mRNA occurs when a ribosome is
blocked during translational elongation by stable RNA secon-
dary structures, depurination of messenger RNA (mRNA), rare
codons, or premature stop codons (Doma and Parker, 2006;
Chen et al., 2010; Kuroha et al., 2010; van den Elzen et al.,
2010). This mRNA is endonucleolytically cleaved in the vicinity
of the stalled site, and the resulting mRNA fragments, with free
30 or 50 termini, are further degraded by exosomes or by Xrn1
exoribonuclease, respectively. It has been suggested that
Dom34:Hbs1 recognizes stalled ribosomes and recruits an
unknown endonuclease(s) (Doma and Parker, 2006; Passos
et al., 2009). Recent biochemical studies clearly show that yeast
Dom34:Hbs1 promotes dissociation of a stalled ribosome into
subunits in vitro (Shoemaker et al., 2010; Pisareva et al., 2011;
Shoemaker and Green, 2011). More recently, it has been
shown that an endonucleolytic cleavage of mRNA in the vicinity
of stalled ribosomes can occur even in the absence of
Dom34:Hbs1 (Passos et al., 2009; Chen et al., 2010; Kuroha
et al., 2010). Therefore, it is still unknown whether dissociation
of the ribosome by Dom34:Hbs1 results in an endonucleolytic
cleavage of mRNA during NGD.
Translation arrest induced by a nascent peptide with positively
charged residues results in cotranslational degradation of the
arrested protein product by the proteasome (Ito-Harashima
et al., 2007; Dimitrova et al., 2009) and endonucleolytic cleavage
of the mRNA (Kuroha et al., 2010). This cleavage occurs even
in the absence of Dom34:Hbs1, and the 50 cleavage product
(which is hereafter referred to as the 50-NGD intermediate) is
detected in a dom34D mutant, but not in the wild-type strain,
even under conditions in which the 30-to-50 exonucleolytic
mRNAdegradation pathway is active (Kuroha et al., 2010). These
results suggest that a ribosome that is stalled at the 30 end of
the 50-NGD intermediate may inhibit degradation of the mRNA
by the exosome. The insertion of a hammerhead ribozyme
sequence (Rz) downstream of a reporter gene results in the
production of mRNA that lacks a stop codon and a poly(A) tail
(which is referred to as stop-codon-less mRNA), and this
mRNA is translated in mutant cells in which exosome degrada-
tion of mRNA from the 30 end is defective (Meaux and Van
Hoof, 2006). Protein synthesis from a stop-codon-less GFP-Rz
mRNA is largely dependent on the Dom34:Hbs1 complex
(Kobayashi et al., 2010), suggesting that the Dom34$Hbs1
complex facilitates efficient dissociation of the stalled ribosome
from the 30 end of stop-codon-less GFP-Rz mRNA. Recent
biochemical analysis clearly demonstrated that mammalian
Pelota:Hbs1, as well as yeast Dom34:Hbs1, in concert with
ABCE1 disassembles ribosome complexes that are stalled at
the 30 end of stop-codon-less mRNAs in vitro (Pisareva et al.,
2011; Shoemaker and Green, 2011). However, as yet there has
been no in vivo evidence demonstrating that Dom34:Hbs1
functions in the dissociation of a ribosome stalled at the 30
end of stop-codon-less mRNA, including 50-NGD intermedi-
ates. In addition, the role of Dom34:Hbs1 in the rapid degra-
dation of aberrant stop-codon-less mRNA has not been
demonstrated.
An aberrant mRNA lacking a termination codon (nonstop
mRNA) is produced mainly by polyadenylation within an open
reading frame (ORF) but is rapidly degraded by a quality control
system designated as nonstop decay (NSD) (van Hoof et al.,
2002; Frischmeyer et al., 2002). The Ski7 protein has been
proposed to dissociate a ribosome that is stalled at the 30 end
of nonstop mRNA and to recruit exosomes for rapid mRNA
degradation (van Hoof et al., 2002). A carboxy-terminal domain
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of Ski7 plays a crucial role in NSD; however, how Ski7 stimulates
the degradation of nonstopmRNA is still unknown. Translation of
nonstop mRNA also results in the synthesis of polylysine by
translation of the poly(A) mRNA sequence that leads to transla-
tion arrest. The level of the product of nonstop mRNA was
reduced 100-fold, and this reduction was due to rapid mRNA
degradation, translation repression, and protein destabilization,
which was mediated, at least in part, by the proteasome (Inada
and Aiba, 2005; Ito-Harashima et al., 2007; Bengtson and Joa-
zeiro, 2010).
In this study, we examined the function of Dom34:Hbs1 in the
release of a stalled ribosome from stop-codon-less mRNAs
including 50-NGD intermediates. Our results provide the
evidence to show that the Dom34:Hbs1 complex stimulates
the release of a stalled ribosome at the 30 end of stop-codon-
less mRNA in vivo. In addition, Dom34:Hbs1 was consistently
shown to be required for degradation of the 50 product of
different NGDs by dissociation of a ribosome that is stalled
at the 30 end of the 50-NGD intermediate. Dom34:Hbs1 also
stimulates the decay of nonstop mRNAs from the 30 end by the
exosome and is required for the complete degradation of
decay intermediates of nonstop mRNA. Finally, we propose
that Dom34:Hbs1 stimulates degradation of stop-codon-less
and nonstop mRNAs by dissociating a ribosome that is stalled
at the 30 end of the mRNA, which makes the released mRNA
more vulnerable to nucleolytic attack, and that Dom34:Hbs1
plays important roles in both NSD and NGD.
RESULTS
Dom34:Hbs1 Stimulates Dissociation of a Ribosome
that Is Stalled at the 30 End of Stop-Codon-less mRNA
We examined the role of Dom34:Hbs1 in the dissociation of
a ribosome that is stalled at the 30 end of stop-codon-less
mRNA in vivo. The insertion of an Rz sequence downstream of
a reporter gene results in the production of a 50-capped stop-
codon-less mRNA, which is translated in ski2D mutant cells
(Meaux and Van Hoof, 2006). We showed that the Dom34:Hbs1
complex is required for protein synthesis from the stop-codon-
less GFP-Rz mRNA that is produced from the GFP-Rz-FLAG-
HIS3 reporter gene in a ski2D background (Kobayashi et al.,
2010) (Figure 1A, lanes 1–3). Mutations of Dom34 that may affect
recognition of the stalled ribosome [F47A and D(F47-T60)], or
mutations of the GTP-binding activity of Hbs1 [T232A and
H255A], abolished Dom34:Hbs1 stimulation of protein produc-
tion from the stop-codon-less mRNA. The level of protein
derived from the GFP-Rz mRNA in the ski2D mutant was
significantly decreased when these mutant forms of Dom34
and Hbs1 were expressed, even in the presence of the wild-
type Dom34:Hbs1 complex (Figure 1A, lanes 4–11), indicating
that these mutant forms of the Dom34 and Hbs1 proteins can
dominantly inhibit the activity of wild-type proteins. We specu-
late that proper contact of the Dom34:Hbs1 complex with the
A site of the stalled ribosome, as well as the GTPase activity of
Hbs1, may be directly involved in protein production from the
stop-codon-less mRNA.
We considered that a ribosome that is stalled at the 30 end of
GFP-Rz in the dom34D mutant might contain the peptidyl-tRNA
(transfer RNA) derived from GFP-Rz. It has been reported that
peptidyl-tRNA can be detected by SDS-PAGE under neutral
pH conditions (NuPAGE, Invitrogen), which preserves peptidyl-
tRNA ester bonds, and that peptidyl-tRNA migrates at a molec-
ular weight about 20 kDa higher than that of the polypeptide
alone and corresponds to the size of tRNA. Indeed, the
peptidyl-tRNA that was produced from GFP-Rz was detected
by NuPAGE followed by western blotting in cell extracts of
dom34D and ski2Ddom34D mutants (Figure 1B, lanes 2 and 4),
but not in extracts of wild-type or ski2D mutants (Figure 1B,
lanes 1 and 3). RNase A treatment cleaved this tRNA, yielding
free GFP-Rz peptide fragments, which migrated similarly to
the product derived from GFP-Rz mRNA in the ski2D mutant
(Figure 1B, lanes 6 and 8). These results demonstrate that
Dom34:Hbs1 is required for the dissociation of a ribosome that
is stalled at the 30 end of stop-codon-less mRNA in vivo.
We performed polysome analysis using sucrose density
gradients to confirm that stalled ribosomes contain mRNA
and peptidyl-tRNA derived from GFP-Rz-FLAG-HIS3. GFP-Rz
mRNAs were distributed in polysome fractions in both the ski2D
dom34D and the ski2Dmutants (Figure 1C, top panels) although
the level of protein produced from GFP-Rz mRNA was signifi-
cantly decreased in the ski2Ddom34D mutant (Figure 1A, lanes
1–2), suggesting that translation of GFP-Rz mRNA might be
repressed after initiation in the ski2Ddom34D mutant. The
GFP-Rz protein products were distributed in monoribosome or
diribosome fractions in ski2Ddom34D mutants but almost no in
the ski2D mutant (Figure 1C, bottom panels). NuPAGE followed
by western blotting analysis of ribosome-free, mono-, or diribo-
some fractions of the ski2Ddom34D mutant clearly demon-
strated that the polypeptide that is present in the ribosome
fractions is peptidyl-tRNA (Figure 1D). We obtained essentially
the same results using wild-type and dom34Dmutant cells (Fig-
ure S1A available online). These results indicate that a ribosome
that is stalled at the 30 end of GFP-Rz mRNA in dom34D back-
ground cells contains peptidyl-tRNA and inhibits the recycling
of subsequent ribosomes. In addition, there is a Dom34:Hbs1-
independent mechanism to release the polypeptide from pep-
tidyl-tRNA in the P site of the ribosome that is stalled at the 30
end of mRNA.
We next investigated whether Dom34F47A, Dom34-D(F47-
T60) or Hbs1H255A proteins had dominant negative effects
on the activity of the wild-type Dom34 or Hbs1 proteins. The
levels of peptidyl-tRNA in mono- or diribosome fractions in
ski2D cells expressing Hbs1H255A were comparable with those
of ski2Dhbs1D cells (Figure 1E, bottom panels), indicating that
the Hbs1H255A mutant protein almost completely inhibits the
dissociation of the ribosome that is stalled at the 30 end of
mRNA even in the presence of the wild-type protein. The levels
of peptidyl-tRNA in mono- or diribosome fractions in ski2D cells
expressing Dom34F47A or Dom34-D(F47-T60) were moderately
but significantly higher than those in ski2D cells (Figure 1E, left
panels). These results suggest that Dom34F47A and Dom34-
D(F47-T60) mutant proteins can inhibit the activity of the wild-
type protein although less efficiently than the Hbs1H255A
mutant.
These results indicate that Dom34:Hbs1 is required for disso-
ciation of the ribosome that is stalled at the 30 end of mRNA.
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Figure 1. Dom34:Hbs1 Stimulates Dissociation of a Stalled Ribosome at the 30 End of Stop-Codon-less mRNA
(A) Dom34:Hbs1 plays an essential role in protein production from a stop-codon-less mRNA. The indicated mutant cells were transformed with the p416GPDp-
GFP-Rz-FLAG-HIS3 plasmid, and W303ski2D cells were cotransformed with indicated plasmids (lanes 4–11). Top: Northern blotting with a DIG-labeled GFP
probe. Bottom: Western blotting with an anti-GFP antibody.
(B) Detection of peptidyl-tRNA derived from GFP-Rz stop-codon-less mRNA in dom34D mutant cells. Cell extracts were analyzed by NuPAGE followed by
western blotting with an anti-GFP antibody. The indicated samples (lanes 5–8) were treated with RNase A before NuPAGE. The asterisk indicates nonspecific
bands.
(C) Stalled ribosomes in the dom34 deletionmutant containGFP-RzmRNA and its protein product. Cell extracts were prepared from the indicated cells harboring
the p416GPDp-GFP-Rz-FLAG-HIS3 plasmid, and polysome analysis was performed. Top: Absorbance at 254 nm. Middle: Northern blotting. Bottom: Western
blotting.
(D) The GFP-Rz protein of ribosome fractions in dom34D mutant cells is peptidyl-tRNA derived from GFP-Rz mRNA. Protein samples prepared from each
ribosome fraction in (C) were analyzed as in (B).
(E) Dominant negative effects of Dom34/Hbs1 mutants on the dissociation of peptidyl-tRNA from the stalled ribosome.
(F) Sucrose-gradient fractions of crude extracts ofW303ski2Ddom34D cells expressing theGFP-RzmRNA in the presence of 30mMEDTAwere analyzed as in (E).
See also Figure S1.
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However, it is still unknown how peptidyl-tRNA is hydrolysed
during this reaction. To address this question, we examined
the distribution of peptidyl-tRNA after the dissociation of ribo-
some subunits by Mg2+ depletion using EDTA. Most of the
GFP-Rz protein was distributed as a peptide in the ribosome-
free fraction. The peptidyl-tRNA was distributed both in the
60S subunit fraction and in the ribosome-free fraction (Figures
1F and S1B). We suspect that the peptidyl-tRNA in the P site
of the stalled ribosome might be hydrolysed on the 60S
subunit after dissociation of the subunit by Dom34:Hbs1 and
that putative factors might be responsible for the termination
codon-independent peptide-release reaction. There are two
peptidyl hydrolases in S.cerevisiae, and the level of peptidyl-
tRNA derived from GFP-Rz mRNA was not increased in
a pth1Dpth2Dski2D mutant (Figure S1C), suggesting that these
factors are not responsible for this activity.
Dom34:Hbs1 Stimulates the Degradation
of Stop-Codon-less mRNAs from the 30 End
As shown in Figure 1C, the distribution of peptidyl-tRNA in the
sucrose gradients of ski2Ddom34D mutant cell extracts did not
correlate with that of GFP-Rz mRNA. To determine whether
stalled ribosomes at the 30 end of GFP-Rz mRNA in the
dom34D mutant cell might affect the fate of this mRNA, we per-
formed northern blotting with probes corresponding to three
different regions of GFP. A short mRNA fragment was detected
with the G3 probe, which hybridizes to 70 nucleotides (nt) at
theGFP 30-end region, only in a dom34D background (Figure 2A,
lanes 14, 16, 18). The level of this short fragment that corre-
sponds to the 30-end region of GFP was significantly increased
in an xrn1Ddom34D background compared to a wild-type
dom34D or a ski2Ddom34D background (Figure 2A, lane 18
versus lanes 14 and 16, respectively), strongly suggesting that
Figure 2. Dom34:Hbs1 Stimulates Degradation of Stop-Codon-less mRNAs by Exosomes
(A) Northern blotting with DIG-labeled probes corresponding to the 50 (G1), middle (G2), and 30 (G3) regions ofGFP. The sequences of the G1, G2, and G3 probes
are listed in Table S2.
(B) Multiple endonucleolytic cleavages of GFP-Rz mRNA in a dom34D mutant background. RNA samples were prepared from the indicated cells harboring the
p416GAL1p-GFP-Rz-FLAG-HIS3 plasmid and were analyzed by 6% TBE-Urea PAGE and northern blotting with a DIG-labeled G3 probe.
(C) The Dom34:Hbs1 complex stimulates the degradation of GFP-Rz mRNA from the 30 end. The half-lives of GFP-RzmRNAs are shown as the mean values of
three independent experiments with standard deviations.
(D) The production of small fragments fromGFP-RzmRNA in a dom34D background. The half-lives ofGFP-Rz and its truncated small fragments were determined
in the indicated mutants.
See also Figure S2.
Molecular Cell
Dom34:Hbs1 Is Involved in NGD and NSD
Molecular Cell 46, 518–529, May 25, 2012 ª2012 Elsevier Inc. 521
an endonucleolytic cleavage may be induced by a ribosome
stalled at the 30 end of GFP-RzmRNA. TBE-urea-PAGE analysis
of these samples followed by northern blotting using a G3 probe
demonstrated that a ladder of NGD products was derived from
the 30 region ofGFP-RzmRNA. The difference in length between
each band of the ladder was about 30 nt and this difference may
correspond to 28 nt (Figure 2B), the length of mRNA that is
covered by individual ribosomes (Ingolia et al., 2009). Based
on these data we propose that a stalled ribosome at the 30 end
of GFP-Rz mRNA in dom34D mutant cells induces an endonu-
cleolytic cleavage.
We next examined the role of Dom34:Hbs1 in the stability of
GFP-Rz mRNA. The GFP-Rz mRNA was more stable in the
ski2D mutant (t1/2 = 8.6 min) in which the 30-to-50 degradation
pathway mediated by exosomes is defective, than in the wild-
type strain (t1/2 = 2.2 min) (Figure 2C). This result indicates that
GFP-Rz mRNA is rapidly degraded by exosomes from the 30
end as previously reported (Meaux and Van Hoof, 2006).
The results shown above indicate that Dom34:Hbs1 is
required for dissociation of a ribosome that is stalled at the 30
end of GFP-Rz mRNA. Therefore, we suspected that, in the
absence of Dom34:Hbs1, access of exosomes to a ribosome
that is stalled at the 30 end may be inhibited, thereby leading to
stabilization of GFP-Rz mRNA. Figure 2C shows that, as ex-
pected, GFP-Rz mRNA was more stable in dom34D or hbs1D
mutants (t1/2 = 4.6 and 3.8 min, respectively) than in the wild-
type strain (t1/2 = 2.2 min). Moreover, GFP-Rz mRNA was signif-
icantly more stable when Dom34 was absent from the xrn1D
mutant in which only the 30-to-50 degradation pathway is active
(t1/2 > 32 min, xrn1Ddom34D mutant) than when Dom34 was
present (t1/2 = 4.3 min, xrn1D). The stability of GFP-FLAG-HIS3
mRNA was not affected by dom34D or hbs1D mutations in
a wild-type or an xrn1D background (Figure S2). These results
clearly indicate that Dom34:Hbs1 stimulates degradation of
GFP-Rz mRNA from the 30 end.
The GFP-Rz mRNA was also more stable in xrn1D cells ex-
pressing Dom34F47A, Dom34D(F47-T60) or Hbs1H255Amutant
proteins (Figure 2C), which dominantly inhibit the effect of their
respective wild-type protein on protein production from the
stop-codon-less mRNA (Figure 1E). Importantly, the efficiency
of dominant negative mutants in dissociating a stalled ribosome
nicely correlates with the stabilization of GFP-RzmRNA in xrn1D
cells. The Hbs1H255A mutant showed the strongest effect on
the inhibition of peptidyl-tRNA release from the ribosome (Fig-
ure 1E) and on the degradation of GFP-Rz mRNA (Figure 2C).
Based on these data, we propose that dissociation of the stalled
ribosome from stop-codon-less mRNA through the activity of
Dom34:Hbs1 is required for exosomes to access the free 30
end of this stop-codon-less mRNA and subsequently to induce
its rapid degradation.
The above data show that the GFP-Rz mRNA is less stable in
dom34D or ski2Ddom34D mutant cells than in ski2D mutant
cells. We next determined the levels of both the full-length and
truncated small fragments derived from GFP-Rz mRNA after
the shutoff of transcription in ski2D, dom34D, or ski2Ddom34D
mutant cells (Figure 2D). The levels of truncated small fragments
derived from full-length GFP-Rz mRNA peaked at 4 min after
shutoff and were still detectable after the disappearance of
full-length GFP-Rz mRNA in dom34D or ski2Ddom34D mutant
cells but not in ski2Dmutant cells. These results strongly suggest
that sequential endonucleolytic cleavages occur in the dom34D
mutant cells that reduce the level of the full-length mRNA, and
that the effect of deletion of Dom34 on the stabilization of
stop-codon-less mRNA might be underestimated.
Dom34:Hbs1 Stimulates Degradation of 50-NGD
Intermediates
It has been reported that translation arrest induced by basic
amino acid sequences induces Dom34-independent NGD
(Kuroha et al., 2010). In our reporter system, translation of GFP
will occur before any of the tester sequences are encountered
by the ribosome. We determined whether endonucleolytic
cleavage of mRNA is induced by other consecutive amino acid
residues and found that (G)-rich nucleotide sequences could
induce an endonucleolytic cleavage of mRNA in a translation-
dependent manner (Figures S3A and S3B). Further analysis of
NGD in dom34D or hbs1D mutants indicated that Dom34:Hbs1
stimulates but is not required for NGD induced by (G)-rich
nucleotide sequences (Figure 3A, lanes 4–6 and 10–12). Impor-
tantly, the 50-NGD intermediate derived from the GFP-GGN12-
FLAG-HIS3 gene was detected in dom34D or hbs1D mutants
even under conditions in which the 30-to-50 exonucleolytic
mRNA degradation pathway is active, but this intermediate
was not detected in the wild-type strain (Figure 3A, lanes 1–3).
These results suggest that a ribosome stalled at the 30 end
of the 50-NGD intermediate may inhibit mRNA degradation
by exosomes. We next evaluated the role of Dom34:Hbs1 in
NGD induced by a stem-loop structure, 12 GGN repeats,
tandem rare CGA codons, or polylysine sequences. In these
NGDs, the Dom34:Hbs1 complex stimulates, but is not essential
for, endonucleolytic cleavage of the mRNAs (Figure 3B, lanes
4–15). This is consistent with recent results that yeast
Dom34:Hbs1 dissociates stalled ribosome containing 60 nt
mRNA downstream of P site, although a stalled ribosome with
a shorter 30 untranslated region (UTR) is a better substrate (Shoe-
maker and Green, 2011).
We previously reported that the 50 cleavage product of NGD
that is induced by polylysine and polyarginine is significantly
stabilized in the dom34D mutant, even under conditions in
which the 30-to-50 exonucleolytic mRNA degradation pathway
is active (Kuroha et al., 2010). We therefore examined the
function of Dom34:Hbs1 in the degradation of 50-NGD intermedi-
ates derived from four different NGDs. The 50-NGD intermediates
of NGDs resulting from 12 repeats of the GGN codon, a run of
rare codons, or a polylysine sequence were clearly detected
in the dom34D mutant even under conditions in which the
30-to-50 exonucleolytic mRNA degradation pathway is active.
However, these intermediates were not detected in the wild-
type strain (Figure 3C). Polysome analysis showed that the pep-
tidyl-tRNA that was produced from the 50-NGD intermediate of
GFP-K12-FLAG-HIS3mRNAwas distributed in monosome frac-
tions of ski2Ddom34Dmutants but not in monosome fractions of
the ski2D mutants (Figure S3D), although the level of protein
produced from 50-NGD intermediate was significantly decreased
in the ski2Ddom34D mutant (Figure 3B, lanes 13 and 14). These
results suggest that Dom34:Hbs1 is required for the dissociation
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of a ribosome that is stalled at the 30 end of the 50-NGD interme-
diate of GFP-K12-FLAG-HIS3 mRNA.
To clarify the role of Dom34:Hbs1 in the degradation of the
50-NGD intermediate, we next measured the half-life of the 50
intermediates of NGD induced by 12 GGN repeats and polyly-
sine sequences. As expected, both full-length mRNAs and
50-NGD intermediates were detected in the ski2D mutant (Fig-
ure S3E), but not in the wild-type strain, 30 min after induction
of transcription (Figure 3D). Truncated GFP fragments were not
detected in the ski2D mutant when translation was inhibited by
cycloheximide during transcription induction (Figure S3E). These
results indicate that, as expected, production of the truncated
GFP fragments requires translation. Since the 50-NGD interme-
diate could be produced from full-length mRNAs even when
transcription was inhibited it is difficult to estimate the stability
of the 50-NGD intermediate. However, the 50-NGD intermediate
that is produced from the full-length mRNAs could be detected
in the dom34Dmutant but not in the wild-type strain (Figure 3D).
We therefore conclude that the 50-NGD intermediates are stabi-
lized in the dom34Dmutant. Based on these results, we propose
that Dom34:Hbs1 dissociates a ribosome that is stalled at the 30
end of a 50-NGD intermediate and facilitates degradation of the
mRNA by exosomes in these NGD pathways.
The Endonucleolytic Cleavages that Occur in NGDs
Take Place Mainly upstream of the Stalled Ribosome
To clarify how ribosomes are stalled by roadblock elements,
tandem rare codons, or the synthesis of polylysine, we mapped
the 50 ends of the truncated 30 HIS3 fragments in the wild-type
and the dom34D, xrn1D mutants using primer extension experi-
ments. The reverse transcription is inhibited by the strong
secondary structures, and no 50 ends of the truncated 30 HIS3
fragments in the xrn1D mutant were mapped upstream of
arrest-inducing sequences (Figure 4A, lanes 5–8). In addition,
no 50 ends of the truncated 30 HIS3 fragments were mapped
downstream of arrest-inducing sequences, indicating that an
endonucleolytic cleavage may not occur downstream of stalled
ribosome. Several 50 ends of the truncated 30 HIS3 fragments
derived from GFP-Rare-FLAG-HIS3 mRNA were detected in
the wild-type cells (Figure 4A, lane 13). The distance between
each of these bands was 30 nt (Figure 4B), which is similar to
the length of mRNA that is covered by an individual ribosome (In-
golia et al., 2009). Since exonucleolytic cleavage by Xrn1 is
highly processive, we assume that degradation from the 50 end
by Xrn1 could only be inhibited by a ribosome that is stably
stalled on the mRNA. Based on this assumption, we propose
that a ribosome that is translating tandem rare codons may stall
Figure 3. Dom34:Hbs1 Stimulates Degradation of 50-NGD Intermediates by Exosomes
(A) Dom34:Hbs1 stimulates the endonucleolytic cleavage induced by a (G)-rich sequence. The indicated mutant cells harboring the p416GPDp-GFP-(GGN)12-
FLAG-HIS3 plasmid were analyzed by northern blotting.
(B) Dom34:Hbs1 is not essential for mRNA endonucleolytic cleavage in various NGDs but plays an essential role in protein production from the 50-NGD inter-
mediate. W303ski2D, W303ski2Ddom34D, and W303ski2Dhbs1D cells harboring control p416GPDp-GFP-FLAG-HIS3 (–), p416GPDp-GFP-SL-FLAG-HIS3 (SL),
p416GPDp-GFP-(GGN)12-FLAG-HIS3 [(GGN)12], p416GPDp-GFP-rare codons-FLAG-HIS3 (Rare), or p416GPDp-GFP-K12(AAA)-FLAG-HIS3 (K12) plasmids
were analyzed. Top: Northern blotting. Bottom: Western blot analysis.
(C) 50-NGD intermediates (IM) are detectable in dom34Dmutants. RNA samples fromW303, W303dom34D andW303hbs1D cells harboring the plasmids shown
in (B) were analyzed by northern blotting.
(D) 50-NGD intermediates are stabilized in dom34Dmutants. The stability of 50-NGD intermediates derived from the reporters under the control ofGAL1 promoter
was determined after transcription shutoff by the addition of glucose.
See also Figure S3.
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and block themovement of subsequent ribosomes. Bands of the
same size were mapped in dom34D mutants, but the intensities
of these bands were moderately decreased compared to
those in the wild-type cells (Figure 4A, lane 14). The 50 ends of
the truncated 30 HIS3 fragments derived from the GFP-Rare-
FLAG-HIS3 mRNA in the xrn1D mutant were mapped upstream
of the CGA rare codons (Figure 4A, lane 15; Figure 4B). This
indicates that 50-NGD intermediates have no arrest-inducing
tandem rare codons, and is consistent with previous result
(Chen et al., 2010).
In contrast to the detection of rare codons, we could barely
detect the 50 ends of the truncated 30 HIS3 fragments derived
from GFP-K12-FLAG-HIS3 mRNA in the wild-type and the
dom34D mutant (Figure 4A, lanes 21 and 22). Most of the 50
ends of the truncated 30 HIS3 fragments derived from GFP-
K12-FLAG-HIS3 mRNA in the xrn1D mutant mapped just
upstream of the poly(A) sequences (Figure 4A, lane 23; Fig-
ure 4B), and the majority of the resulting stop-codon-less
mRNA had no arrest-inducing rare codons. These data suggest
that the stalling of a ribosome during translation of a poly(A)
sequence indeed induces an endonucleolytic cleavage but that
the binding of the stalled ribosome to the mRNA might not be
stable enough to block the degradation of the mRNA from the
50 end by Xrn1. How ribosomes that are stalled on the 30-NGD
intermediate can be disassembled by Dom34:Hbs1:ABCE1 is
important. In the most recent paper, it was reported that the
dissociation activity of these factors depends on the length of
the 30-terminal portion of the mRNA in yeast (Shoemaker and
Green, 2011), just as was reported for the mammalian system
(Pisareva et al., 2011). The 50 ends of the 30-NGD intermediates
derived from GFP-rare-FLAG-HIS3 or GFP-K12-FLAG-HIS3
mRNA that we detected in the xrn1Ddom34Dmutant (Figure 4A,
lanes 16 and 24) were almost the same as those in the xrn1D
mutant (Figure 4A, lanes 15 and 23), except that the intensities
of the bands were reduced in the xrn1Ddom34D mutant. The
distributions of the 30-NGD intermediates of GFP-rare-FLAG-
HIS3 orGFP-K12-FLAG-HIS3 in polysome fractions were almost
the same in the xrn1Ddom34D mutant as in the xrn1D mutant
(Figure S4). Therefore, the role of Dom34:Hbs1 in the dissocia-
tion of stalled ribosome translating arrest sequences under this
experimental condition is still unclear.
Dom34:Hbs1 Stimulates the Decay of Nonstop mRNA
It has been proposed that nonstop mRNA is rapidly degraded
from the 30 end independent of deadenylation and that
Ski7p may dissociate a ribosome that is stalled at the 30 end
Figure 4. Endonucleytic Cleavages by Translation Arrest Occur Mainly on the 50 Side of Stalled Ribosomes
(A) Primer extension experiments were performed with radiolabeled primers complementary to a region near the 50 end of the HIS3 fragment. The arrowheads
indicate the 50 ends of 30-NGD intermediate derived from reporter genes in the indicatedmutants (X, rare in XRN1 background; R, rare in an xrn1D background; K,
K12 in an xrn1Dbackground) (lanes 13–16and21–24). The red line represents the insertionbetweenGFPandFLAG-HIS3. The sequencing reactionwasperformed
with the GFP-(GGN)12-FLAG-HIS3 (lanes 1–4), the GFP-Rare-FLAG-HIS3 (lanes 9–12), or the GFP-K12-FLAG-HIS3 (lanes 17–20) plasmid as a template.
(B) The positions of the 50 ends of the 30 NGDs determined in the primer extension experiments in (A) are indicated by arrowheads.
See also Figure S4.
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of nonstop mRNA and recruit exosomes for rapid mRNA degra-
dation (van Hoof et al., 2002). We also found that the HIS3-
nonstop (his3-ns) mRNA that was stabilized in xrn1D mutant
cells was mainly polyadenylated RNA, although the majority
of the HIS3 mRNA in the xrn1D mutant was deadenylated (Fig-
ure S5). This result suggests that his3-ns mRNA is also rapidly
degraded from the 30 end, independent of deadenylation, as
has been reported for PGK1-nonstop mRNA (van Hoof et al.,
2002). Our results indicate that Dom34:Hbs1 dissociates a ribo-
some that is stalled at the 30 end of stop-codon-less mRNAs,
including GFP-Rz mRNA and 50-NGD intermediates. We there-
fore suspected that Dom34:Hbs1 might also dissociate a ribo-
some that is stalled at the 30 end of nonstop mRNA. A second
possibility was that translation arrest by a poly(A) tail may
induce an endonucleolytic cleavage and that Dom34:Hbs1
may stimulate degradation of the resulting stop-codon-less
mRNA.
Nonstop HIS3 (his3-ns) mRNA has been reported to be rapidly
degraded from both the 50 and the 30 ends of the mRNA (Inada
and Aiba, 2005). Furthermore, although his3-nsmRNA is moder-
ately, but significantly, stabilized in a ski7D mutant it is much
more stable when both of the degradation pathways are defec-
tive (Inada and Aiba, 2005). To confirm the role of Dom34:Hbs1
in the decay pathway for nonstop mRNA, we determined the
stability of nonstop his3-nsmRNA in dom34Dmutants.We found
that the stability of his3-ns mRNA was not very high in an xrn1D
mutant (t1/2 = 11.2 min), but that it was dramatically increased in
an xrn1Ddom34D double mutant (t1/2 > 32min; Figure 5A). More-
over, his3-ns mRNA was more stable in xrn1D cells in which the
mutant Dom34F47A, Dom34D(F47-T60) or Hbs1H255A proteins
were expressed (t1/2 = 22.9 min, t1/2 = 21.6 min and > 32 min,
respectively; Figure 5A). As shown above, these mutants domi-
nantly inhibit the activity of their respective wild-type protein in
protein production from the stop-codon-less mRNA (Figure 1).
These results indicate that Dom34:Hbs1 stimulates the degrada-
Figure 5. Dom34:Hbs1 Stimulates the
Decay of Nonstop mRNA
Wild-type and the indicated mutant cells harboring
the yCplac33GAL1p-His3-ns (his3-ns) (A) or the
p416GAL1p-RNA14 (RNA14-ns) plasmid (B) were
grown, and the half-lives of the mRNAs were
determined as described in Figure 3. Black arrows
indicate RNA14 full-length mRNA and red arrows
indicate RNA14-ns mRNA. See also Figure S5.
tion of nonstop mRNA from the 30 end by
dissociating the stalled ribosome at the 30
end of nonstop mRNA.
It was reported that nonstop mRNAs
are produced by polyadenylation within
an ORF in yeast and mammals. The
RNA14 gene under the control of the
GAL1 promoter produces nonstop
mRNA by polyadenylation within an ORF
as previously reported (Figure 5B). To
confirm the function of Dom34:Hbs1 in
quality control of endogenous nonstop
mRNA, we measured the stability of endogenous nonstop
mRNA expressed from RNA14, RNA14-ns. We found that the
stability of RNA14-ns was not very high in an xrn1D mutant (t1/
2 = 18.1 min) or a ski2D mutant (t1/2 = 5.3 min), but that it was
dramatically stabilized in an xrn1Ddom34D double mutant (t1/2
> 32 min; Figure 5B), although the stability of full-length normal
RNA14 mRNA was almost the same in xrn1D mutant cells and
in xrn1Ddom34D double-mutant cells (Figure 5B). These results
indicated that Dom34:Hbs1 dissociates a ribosome that is
stalled at the 30 end of nonstop mRNA and stimulates the degra-
dation of nonstop mRNA by exosomes in yeast.
Stalled Ribosomes Induce Sequential Endonucleolytic
Cleavages
To determine the degradation pathway of nonstop mRNA and
the role of Dom34:Hbs1 in nonstop mRNA decay, we analyzed
the truncated mRNAs that were produced in dom34D mutant
cells. A ladder of small fragments derived from his3-ns mRNA,
but not from HIS3 mRNA, in xrn1Ddom34D mutant cells was
detected by PAGE analysis of cell extracts followed by northern
blotting with a probe corresponding to the 30 UTR of HIS3
(30 UTR) (Figure 6A, lanes 12 and 6, respectively). This result
indicated that an endonucleolytic cleavage takes place within
the ‘‘30 UTR region’’ of his3-ns mRNA but not within that of
HIS3 mRNA. The difference in the length of the NGD product
bands derived from his3-ns mRNA in the xrn1Ddom34D mutant
cells may correspond to the mRNA length that is covered by an
individual ribosome (Figure 6A, lane 12), similar to the ladder
that was produced from GFP-Rz in xrn1Ddom34D mutant
cells (Figure 2B). RNase H treatment of these samples with
oligo-dT followed by northern blotting indicated that these
NGD products derived from his3-ns mRNA do not contain
a poly(A) tail (Figure 6B, lanes 5 and 6). By using northern blotting
with three probes, each corresponding to a different region of
the 30 UTR of HIS3 (NS1, NS2, NS3) (Figure 6C) or with a probe
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corresponding to the ORF of HIS3 (Figure S6), we detected
almost the same products as those detected by northern blotting
with the 30 UTR probe (Figure 6C). These results indicate that
his3-ns mRNA is endonucleolytically cleaved in a random
manner and that cleavage may be induced by a ribosome that
is stalled at the 30 end of NGD products in dom34Dmutant cells.
Based on these results, we suspected that, in dom34D mutant
cells, the stop-codon-less mRNA may be produced from
nonstop mRNA and that subsequent ribosomes may stall at
the 30 end and induce an endonucleolytic cleavage(s). Consis-
tent with this hypothesis, a ladder of small fragments derived
from his3-ns mRNA in ski2Ddom34D mutant cells was detected
by PAGE analysis followed by northern blotting with a probe
corresponding to the 30 UTR of HIS3 (30 UTR) (Figure 6A, lane
10). These data indicate that truncated his3-ns mRNAs lacking
various 50 regions were stabilized in ski2Ddom34D mutant cells.
We consider that a ribosome that is stalled at the 30 end of NGD
products might inhibit mRNA degradation from the 50 end in the
ski2Ddom34D mutant by blocking the movement of subsequent
ribosomes. We also tried to detect the first stop-codon-less
mRNA produced from nonstop mRNA in dom34D mutant cells
that may contain poly(A) and a short 30 UTR region, by northern
blotting with LNA-oligod(T)21. A short fragment of approximately
65 nt was detected in ski2Ddom34D mutant cells harboring
a multicopy his3-ns reporter gene, but less in cells harboring
a HIS3 wild-type gene (Figure 6D, lanes 7 and 8). This fragment
may be the 30 intermediate produced by NGD that is induced
by a stalled ribosome at the 30 end of nonstop mRNA. Finally,
we propose that the Dom34:Hbs1 complex stimulates the
degradation of this mRNA by dissociating the ribosome that is
stalled at the 30 end of nonstop mRNA. In dom34D mutant cells,
a stalled ribosome at the 30 end of nonstop mRNA may inhibit
Figure 6. Stalled Ribosomes Induce Multiple Endonucleolytic Cleavages of Nonstop mRNA
(A) Wild-type and the indicated mutant cells harboring the yCplac33GAL1p-HIS3 (pIT826) (HIS3) or yCplac33GAL1p-His3-ns (pIT827) (his3-ns) plasmid were
grown in SC-Gal Ura medium. RNA samples were analyzed by 6% TBE-Urea PAGE and northern blot analysis with a DIG-labeled 30 UTR probe.
(B) Yeast dom34D cells harboring the yCplac33GAL1p-His3-ns (pIT827) plasmid were grown in SC-Gal Ura medium. Where indicated (+), RNA samples were
digested with RNase H after hybridization with oligo dT (dT). RNA samples were analyzed as in (A).
(C) Top: Schematic drawing of HIS3 and his3-nsmRNAs. The filled box indicates the open reading frame, the line represents nontranslated regions, and the tract
of As denotes the poly(A) tail. The probes used for northern hybridization (NS1–NS3) are shown as bold lines. Bottom: W303dom34D cells harboring the
yCplac33GAL1p-His3-ns (pIT827) plasmid were grown in SC-Gal Ura medium. RNA samples were analyzed as in (A) with a DIG-labeled 30 UTRNS1, NS2, or NS3
probe.
(D) Wild-type and the indicated mutant cells harboring the yEplac195GAL1p-HIS3 (WT) or the yEplac195GAL1p-His3-ns (NS) plasmid were grown in SC-Gal Ura
medium. RNA samples were analyzed as in (A) with a DIG-labeled LNA-oligo dT probe. The arrowhead indicates a putative 30 intermediate of NGD that is induced
by stalled ribosome at the 30 end of nonstop mRNA.
See also Figure S6.
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the degradation of nonstop mRNA by exosomes but induce
sequential endonucleolytic cleavages.
The Carboxy-Terminal Domain of Ski7 Stimulates
the Degradation of Nonstop mRNA Independent
of the Dom34:Hbs1 Complex
To address the relationship between Don34:Hbs1 and Ski7, the
stability of stop-codon-less mRNA (GFP-Rz) and nonstop mRNA
(his3-ns) was determined. Both mRNAs were stabilized in ski2D
(Figures 2C and 5A) and ski7Dmutants (Figure 7A), in which exo-
some activity is defective. The his3-nsmRNAwas destabilized in
the ski7D mutant when the Ski7 protein, but not the mutant
protein that lacks a carboxy-terminal domain (Ski7-DCTD), was
expressed (Figure 7A, left panels). The level of Ski7-DCTD ex-
pressed from the GPD1 promoter was almost the same as that
of Ski7 expressed from the ADH1 promoter (Figure S7). The
his3-ns mRNA was stabilized by Ski7-DCTD even under condi-
tions where the levels of Ski7-DCTD and Ski7 were almost equiv-
alent (Figure 7A, left panels). This result is consistent with
previous results that Ski7-CTD is important for the rapid degra-
dation of nonstop mRNA (van Hoof et al., 2002). The stabilization
of nonstop mRNA by the deletion of Ski7-CTD is also evident in
a dom34D mutant background, suggesting that the role of Ski7-
CTD in stimulating the decay of nonstop mRNAmay be indepen-
dent of Dom34:Hbs1 function. The stability of GFP-FLAG-HIS3
or HIS3 mRNA was not affected by ski7D mutations in wild-
type or xrn1D backgrounds (Figure S2).
It has been proposed that Ski7p may dissociate a ribosome
that is stalled at the 30 end of nonstop mRNA and that Ski7-
CTD is essential for this activity (van Hoof et al., 2002). Peptidyl-
tRNA derived from GFP-Rz mRNA was detected in a ski7D
Figure 7. Dom34:Hbs1 and the Carboxy-
Terminal Domain of Ski7 Independently
Play a Crucial role in NSD
(A) The Ski7 carboxy-terminal domain (CTD)
stimulates the degradation of his3-ns mRNA but
not GFP-Rz mRNA. An intact Ski7 or Ski7-DCTD,
a mutant that lacks a Ski7-CTD, was expressed
under the control of the indicated promoters by the
indicated plasmids. The half-lives of his3-ns (left)
or GFP-Rz (right) mRNAs are shown as the mean
values of three independent experiments with
standard deviations (see also Figure S2).
(B) Ski7 may not be involved in the dissociation of
peptidyl-tRNA from a ribosome that is stalled
at the 30 end of mRNA. Cell extracts were pre-
pared from the indicated yeast cells harboring
the p416GPDp-GFP-Rz-FLAG-HIS3 plasmid, and
sucrose-gradient fractions were analyzed as in
Figure 1D.
See also Figure S7.
dom34D mutant but not in ski7D or ski7D
ski2D mutants, indicating that Ski7 is not
required for dissociation of a ribosome
that is stalled at the 30 end of mRNA or
for peptide release from peptidyl-tRNA
in the stalled ribosome (Figure 7B). This
result was consistent with the fact that GFP-Rz mRNA was
destabilized in the ski7D mutant when a Ski7 or a Ski7-DCTD
mutant protein was expressed (Figure 7A, right panels), as
previously reported (Meaux and Van Hoof, 2006). Finally,
we propose that Ski7-CTD plays a crucial role in the rapid
degradation of nonstop mRNA in an Dom34:Hbs1-independent
manner.
DISCUSSION
In this paper we have demonstrated important functions of the
Dom34:Hbs1 complex in degradation of aberrant mRNA in vivo.
Several lines of evidence in the present study strongly support
the hypothesis that Dom34:Hbs1 dissociates a ribosome that
is stalled at the 30 end of stop-codon-less mRNAs in vivo. First,
Dom34:Hbs1 is required for the production of protein from
stop-codon-less mRNAs including GFP-Rz mRNA (Figure 1A)
and from 50-NGD intermediates that are produced by translation
arrest that was induced by four different elements (Figure 3B).
Second, peptidyl-tRNAs derived from stop-codon-less mRNAs
were detected in ribosome fractions of dom34D or ski2D
dom34D mutant cell extracts but almost none were detected in
extracts of a ski2D mutant (Figures S1A and 1C). Based on
these results, we propose that Dom34:Hbs1 dissociates a ribo-
some that is stalled at the 30 end of stop-codon-less mRNA
in vivo. Protein products derived from stop-codon-less GFP-Rz
mRNAwere also detected in the ribosome-free fraction of a ski2D
dom34D mutant (Figures 1C and 1E), indicating that a ribosome
that was stalled at the 30 end of stop-codon-less GFP-RzmRNA
could be partially dissociated in the absence of the Dom34:Hbs1
complex.
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Several reports have shown that an endonucleolytic cleavage
of mRNA in the vicinity of stalled ribosomes can occur even in the
absence of Dom34:Hbs1 (Passos et al., 2009; Chen et al., 2010;
Kuroha et al., 2010). Thus, although Dom34:Hbs1 stimulates
cleavage, this stimulation may not be the only mechanism for
the mRNA cleavage induced by translation arrest. In this study
we also showed that the Dom34:Hbs1 complex facilitates endo-
nucleolytic cleavage of mRNA in four different NGDs. Based on
the combined data, we propose a dual function of Dom34:Hbs1
in NGD; stimulation of an endonucleolytic cleavage of mRNA, as
well as stimulation of the degradation of a 50-NGD intermediate
by release of a ribosome that is stalled at the 30 end of the
mRNA (Figure S8).
Endonucleolytic cleavage of mRNA in the vicinity of a stalled
ribosome results in the production of two truncated mRNAs
that are decay intermediates, as well as a 50-NGD intermediate
that is rapidly degraded by exosomes. Based on the results of
the present study, we propose that Dom34:Hbs1 stimulates
degradation of the 50-NGD intermediate. First, 50-NGD interme-
diates were detected in the dom34D mutant even under condi-
tions in which the 30-to-50 exonucleolytic mRNA degradation
pathway is active (Figure 3C). Second, 50-NGD intermediates
were detected after transcription shutoff in the dom34D mutant
but were not detected in the wild-type strain even before tran-
scription shutoff (Figure 3D). These results lead us to conclude
that Dom34:Hbs1 is required for rapid degradation of the
50-NGD intermediate, which is achieved by dissociation of a
stalled ribosome at the 30 end. Consistent with these data,
Dom34:Hbs1 stimulates degradation of GFP-Rz mRNA, which
is a stop-codon-less mRNA that is produced without translation
arrest (Figure 2C). In contrast, the role of Dom34:Hbs1 in the
distribution of 30-NGD intermediates and in determination of
the site of endonucleolytic cleavage was not clear under the
conditions used (Figures 4A and S4).
The results presented in this study indicate that Dom34:Hbs1
stimulates degradation of nonstop mRNA from the 30 end by
dissociating the stalled ribosome at the 30 end of nonstop
mRNA (Figure 5). A ribosome that is stalled at the 30 end of
a poly(A) tail in the dom34D mutant protects the nonstop
mRNA from degradation by exosomes from the 30 end (Figure 5).
This stalled ribosome also induces an endonucleolytic cleavage
ofmRNA and results in the production of stop-codon-lessmRNA
(Figure 6). The ribosome that is translating the stop-codon-less
mRNA is stalled at the 30 end of themRNA, and againmay induce
an endonucleolytic cleavage. Therefore, in the dom34D mutant,
a ribosome that is stalled at the 30 end of nonstop mRNA may
trigger sequential endonucleolytic cleavages that result in the
production of stop-codon-less mRNA fragments. We suspect
that this cleavage may account for the results that showed that
peptidyl-tRNA derived from GFP-Rz mRNA in the dom34D
mutant cells was distributed mainly in monosomes (Figure 1C).
Identification of a putative endonuclease is crucial for under-
standing themechanism of thesemRNA quality control systems.
It was recently shown that Rrp44, a component of exosomes that
possess 30 exonuclease activity, also has an endonuclease
activity (Schneider et al., 2009 Schaeffer et al., 2009) and is in-
volved in the degradation of PGK1pG-nonstopmRNA (Schaeffer
and van Hoof, 2011). Therefore, it remains to be determined if
Rrp44 is responsible for the endonucleolytic cleavage that is
induced by a stalled ribosome at the 30 end of nonstop mRNA.
It has been proposed that Ski7 recognizes a stalled ribosome
and dissociates the subunits of ribosome that is stalled at the 30
end of nonstop mRNA (van Hoof et al., 2002). Ski7-CTD is not
important for rapid degradation of stop-codon-less mRNA
(Meaux and Van Hoof, 2006), and we also found that Ski7-CTD
stimulates the decay of nonstop mRNA, but not stop-codon-
less mRNA (Figure 7A). Thus, the level of stalled ribosomes
containing peptidyl-tRNA was not increased by deletion of
SKI7 (Figure 7B), indicating that Ski7 may not be involved in
subunits dissociation of ribosome that is stalled at the 30 end
of stop-codon-less mRNA. Since Ski7-CTD stimulates the
decay of nonstop mRNA even in the absence of Dom34 (Fig-
ure 7A), we propose that Ski7-CTD may somehow recognize
ribosome that is stalled at the 30 end of poly(A) tail independent
of Dom34:Hbs1.
Our results indicate that Dom34:Hbs1 stimulates degradation
of the 50 intermediate of NGD and of nonstop mRNA. Since
Dom34:Hbs1 is also involved in nonfunctional ribosomal RNA
decay (Cole et al., 2009; Swisher and Parker, 2009), we
propose a general function of this complex in quality control of
gene expression; Dom34:Hbs1 recognizes aberrant elongation
complexes and induces quality control systems to avoid the
production of potentially harmful protein products in eukaryotes.
EXPERIMENTAL PROCEDURES
Detection of Peptidyl-tRNA
Peptidyl-tRNA was detected with cell extracts and polysome fractions. Cell
extracts were prepared as described previously (Yanagitani et al., 2011),
and polysome analysis was performed as described below. Cell extracts or
polysome fractions were analyzed with NuPAGE (Invitrogen, Carlsbad, CA)
followed by western blotting. For destruction of the RNA moiety of peptidyl-
tRNA, RNase A was added to the samples at a final concentration of
10 mg/ml, and was incubated at 37!C for 10 min.
Polysome Analysis
Yeast cells were grown exponentially at 30!C and were harvested by centrifu-
gation. Cell extracts were prepared as described previously (Inada and Aiba,
2005). The equivalent of 50 A260 units was then layered onto linear 10% to
50% sucrose density gradients. Sucrose gradients (10%–50% sucrose in
10 mM Tris-acetate [pH 7.4], 70 mM ammonium acetate, 4 mM magnesium
acetate) were prepared in 25 3 89 mm polyallomer tubes (Beckman Coulter)
with a gradient master. Crude extracts were layered on top of the sucrose
gradients and were centrifuged at 150,000 g in a P28S rotor (Hitachi Koki,
Japan) for 2.5 hr at 4!C.Gradients were then fractionated (TOWA lab, Tsukuba,
Japan). Polysome profiles were generated by continuous absorbance
measurement at 254 nm with a single path UV-1 optical unit (ATTO Biomini
UV Monitor) connected to a chart recorder (ATTO digital mini-recorder). Frac-
tions of equal volume were collected and processed for northern blotting as
described above.
Northern Blotting with a Polyacrylamide Gel
Total RNAwas resolved by 6% TBE-Urea polyacrylamide gel (Invitrogen) elec-
trophoresis in the presence of urea and was blotted on to Zeta-Probe GT
Genomic Tested Blotting Membranes (Bio-Rad, Hercules, CA) with a Trans-
Blot SD. Semi-Dry Transfer Cell.
Determination of mRNA Stability
Yeast cells were grown in minimal medium containing 2% galactose. Cells
were grown to OD600 = 0.6, harvested, and resuspended inmedium containing
2% glucose to inhibit transcription from the GAL1 promoter. At the times
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indicated, the cells were harvested to prepare RNA samples with hot-phenol.
The mRNA levels of reporter genes were determined by northern blotting with
digoxigenin (DIG) reagents, and nonradioactive probes were prepared by
PCR-based nucleic acid labeling with commercial kits. Bound probes were
detected according to the procedure specified by the manufacturer (Roche,
NJ). The DIG-labeled probes used in this study are listed in Table S3. The inten-
sity of the bands on the blots was quantified with the LAS3000 mini and Multi-
Gauge Ver 3.0 (Fuji Film, Japan). Relative product levels were determined by
comparison to a standard curve by using a series of dilutions of time 0 samples,
just before the addition of glucose. The intensities of bands from the diluted
samples were compared with a standard curve, and the mRNA level relative
to the control mRNA was determined.
Primer Extension
A radiolabeled primer and complementary oligonucleotide were hybridized
from positions +138 to +160 (relative to the HIS3 translational start), and
reverse transcriptase was used to synthesize a single-stranded DNA toward
the 50 end of the RNA. The size of the labeled single-stranded DNA was
determined relative to a sequencing ladder on a sequencing gel. The oligonu-
cleotide 50-TATCGCTAGGGGACCACCCTTTA-30 was radio-labeled with
[g-32P]ATP (PerkinElmer NEG502A, Waltham, MA) with the T4 polynucleotide
kinase (TaKaRa 2021S, Japan). An RNA sample (5 mg) and 0.1 pmol radiola-
beled primer were used for the reaction with SuperScript III Reverse Tran-
scriptase (Invitrogen 18080-093).
Other Methods and Materials
The yeast strains and plasmids used in this study are listed in Table S1.
Plasmid construction is described in Supplemental Experimental Procedures,
and the oligonucleotides used for plasmid construction are described in
Table S2.
SUPPLEMENTAL INFORMATION
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Supplemental Experimental Procedures 
 
Plasmid construction 
Recombinant DNA procedures were carried out as described previously (Sambrook and 
Russell 2006). Two oligonucleotides (5’-CTAGCCGGCGACGACGGA-3’ and 
5’-CTAGTCCGTCGTCGCCGG-3’) were annealed and inserted into the SpeI site of 
pSA144 (p416GPDp-GFP-FLAG-HIS3-CYC1ter) to create the 
p416GPD-GFP-rare-FLAG-HIS3 reporter. An XbaI-SpeI fragment was amplified in a 
polymerase chain reaction (PCR) using the two primers listed in Table S2 and was used to 
replace the corresponding fragment of pSA144 (pGPDp-GFP-FLAG-HIS3-CYC1ter) to 
generate the pGPDp-GFP-X-FLAG-HIS3 reporters listed in Table S1. An oligonucleotide 
(5’-GATCCGATATCCCGTGGAGGGGCGCGTGGTGGCGGCTGC 
AGCCGCCACCACGCGCCCCTCCACGGGATATCG-3’) was self-annealed and inserted 
into the XbaI site of p416GPDp-GFP-GNG12-FLAG-HIS3 or 
p416GPDp-GFP-GUG12-FLAG-HIS to create the 
p416GPDp-SL-GFP-GNG12-FLAG-HIS3 or p416GPDp-SL-GFP-GUG12-FLAG-HIS3 
reporter.  
 To construct pIT2124 (p416GALp-RNA14), an RNA14 ORF was PCR-amplified 
using the primers OTS080 (5’-CGGGATCCATGTCCAGCTCTACGACTCCTGATTTAC 
-3’) and OTS081 (5’-CCATCGATTTAACCTGACTTGGTGCTCTCAACTGTTG-3’), 
and was inserted into the XbaI-BamHI sites of p416GLA1p (Mumberg et al., Nucleic Acids 
Res, 1994).  
Plasmids expressing various FLAG-SKI7 proteins were constructed as follows. 
To construct pIT2115-17, an HindIII-SalI fragment of SKI7 was amplified in a PCR using 
the two primers OIT1311 (5’-CCCAAGCTTCATGGACTACAAGGACGACGACGACA 
AGTCGTTATTAGAGCAATTAGCAAG-3’) and OIT908 (5’-ACGGGTCGACTTACTG 
GCATGCAATTCTGCCAACTGCGATAACC-3’), and was inserted into the HindIII-SalI 
sites of p415ADHp, p415TEFp and p415GPDp. To construct pIT2118-20, an HindIII-SalI 
fragment of SKI7-NTD was amplified in a PCR using the two primers OIT1311 
(5’-CCCAAGCTTCATGGACTACAAGGACGACGACGACAAGTCGTTATTAGAGCA
ATTAGCAAG-3’) and OIT907 (5’-ACGGGTCGACTTAATGGGTGGCAATGAATGA 
ATGAATATC-3’), and was inserted into the HindIII-SalI sites of p415ADHp, p415TEFp 
and p415GPDp. To construct pIT2121, an HindIII-SalI fragment of SKI7-CTD was 
amplified in a PCR using the two primers OIT1312 (5’-CCCAAGCTTCATGGACTACA 
AGGACGACGACGACAAGCTGAATTTGACATGTTTGTTCCTCGG-3’) and OIT908 
(5’-ACGGGTCGACTTACTGGCATGCAATTCTGCCAACTGCGATAACC-3’), and 





Figure S1. Related to Figure 1 
The detection of peptidyl-tRNA derived from GFP-Rz mRNA in the mutants.  
(A) Stalled ribosomes in the dom34ǻ mutant contain GFP-Rz mRNA and its protein 
product. Cell extracts were prepared from the indicated cells harbouring the 
p416GPDp-GFP-Rz-FLAG-HIS3 plasmid and polysome analysis was performed as 
described previously. Top: Elution profile of sucrose density gradients monitored by 
 
 
absorbance at 254 nm. Middle: Northern blotting using a DIG-labeled GFP probe. Bottom: 
Western blotting using an anti-GFP antibody. (B) The GFP-Rz protein of ribosome 
fractions in ski2ǻdom34ǻ mutant cells is peptidyl-tRNA derived from GFP-Rz. Protein 
samples prepared from monoribosome fractions (lanes 1 and 6) of sucrose-gradient were 
analyzed by NuPAGE followed by Western blotting using an anti-GFP antibody. After 
centrifugation through a sucrose-gradients in the presence of 30 mM EDTA (final pH=7.4), 
Protein samples prepared from ribosome-free (lanse 2-3 and 7-8) or 60S ribosome subunit 
fractions (lanes 4-5 and 9-10) were analyzed by NuPAGE and Western blotting. The 
indicated samples (lanes 7-12) were treated with RNase A before NuPAGE as in Fig. 1B.  
(C) The effect of pth1ǻpth2ǻ double mutations on the dissociation of peptidyl-tRNA from 
stalled ribosome. Yeast cell extract was prepared from the ski2ǻpth1ǻpth2ǻ cells 
harbouring the p416GPDp-GFP-Rz-FLAG-HIS3 plasmid. After sucrose-gradient 









Figure S2. Related to Figure 2 
The stability of normal mRNAs in the decay mutants. The half-lives of GFP-FLAG-HIS3 
(Left) or HIS3 (Right) mRNAs in the indicated mutants are shown as the mean values of 





Figure S3. Related to Figure 3 
(A) Consecutive basic amino acid sequences induce translation arrest coupled with an 
endonucleolytic cleavage. W303ski2ǻ cells harbouring the 
p416GPDp-GFP-X12-FLAG-HIS3 plasmid, where X represents the indicated amino acid 
(single letter code), were grown on SC-Ura medium prior to analysis. The SL reporter 
contains a fragment that encodes a stem-loop (SL) structure in the RNA transcript. (B) 
Guanine(G)-rich sequences induce an endonucleolytic cleavage of mRNA. W303ski2ǻ 
cells harbouring the indicated p416GPDp-GFP-X12-FLAG-HIS3 plasmids that contain a 
 
 
(G)-rich sequence were grown on SC-Ura medium prior to analysis. 5'-SL; a stem loop was 
inserted into the 5’ region. (C) Identification of a stalled ribosome containing a 5'-NGD 
intermediate and its protein product in dom34 deletion mutants. Cell extracts were 
prepared from W303ski2ǻ or W303ski2ǻdom34ǻ cells harboring the 
p416GPDp-GFP-K12(AAA)-FLAG-HIS3 plasmid and were used for polysome analysis as 
described previously. Top: Elution profile of the sucrose density gradient monitored by 
absorbance at 254 nm. Middle: RNA samples were prepared and analyzed by Northern 
blotting using a DIG-labeled GFP probe. Bottom: Protein samples were prepared and 
analyzed by Western blotting using an anti-GFP antibody. (D) GFP protein in the 
mono-some fraction in ski2ǻdom34ǻ mutant cells is peptidyl-tRNA derived from 
GFP-K12-FLAG-HIS3. Protein samples prepared from each fraction in (A) were analyzed 
by NuPAGE followed by Western blotting using an anti-FLAG antibody. (E) 5'-NGD 
intermediates are produced in a translation-dependent manner. W303ski2ǻ cells harboring 
p416GAL1p-GFP-K12-FLAG-HIS3 (Top panels) or 
p416GAL1p-GFP-GGN12-FLAG-HIS3 (Bottom panels) plasmids were grown in medium 
containing 2% rahinose. Cells were harvested at the indicated times after the addition of 
2% galactose, and RNA samples were analyzed by Northern blotting using a DIG-labeled 
GFP probe as described. The blot at bottom shows cells that were treated with 
cycloheximide (final concentration 0.1 mg/ml).   
 
Supplemental Information for Figure S3 
It has been reported that translation arrest induced by basic amino acid sequences 
induces Dom34-independent NGD (Kuroha et al., 2010). To determine if endonucleolytic 
cleavage of mRNA is induced by other consecutive amino acid residues, we inserted DNA 
fragments encoding various consecutive 12 amino acid sequences, with a FLAG-tag at the 
C-terminus, between the GFP and HIS3 genes in the p416GPDp vector (Figure S3A). The 
SL reporter contains a fragment that encodes a stem-loop (SL) structure in the RNA 
transcript (Figure S3A, lane 2). The generation of truncated 5' GFP mRNA fragments 
derived from these reporter genes was analyzed in the ski2ǻ mutant in which mRNA 
degradation from the 3’ end by exosomes is defective. We detected 5’ truncated GFP 
fragments derived from the reporter genes that contained sequences encoding poly-glycine 
or poly-tryptophan (Figure S3A, lanes 8 and 23), in addition to the expected 5’ truncated 
GFP fragments from the poly-lysine and poly-arginine reporter genes (Figure S3A, lanes 
11 and 19) Since the glycine codon (GGN) and the tryptophan codon (UGG) each contain 
2 guanine nucleotide residues, we suspected that repeats of a (G)-rich nucleotide sequence 
rather than a specific amino acid sequence might have induced NGD. To determine if other 
(G)-rich nucleotide sequences could induce NGD, we examined NGD induction using 12 
consecutive GNG or GUG codons in this reporter system. Truncated 5' GFP fragments 
derived from these reporter genes were also detected in the ski2ǻ mutant cells (Figure S3B, 
lanes 4 and 6), and inhibition of translation by insertion of a stem-loop (SL) structure into 
the 5’-untranslated region (UTR) completely eliminated NGD (Figure S3B, lanes 8 and 
10). These results indicate that (G)-rich nucleotide sequences could induce an 
endonucleolytic cleavage of mRNA in a translation-dependent manner. We further 
examined the effects of other (G)-rich nucleotide sequences on NGD in ski2ǻҏcells, 
including 6 or 12 consecutive GGN codons, 2 repeats of G8A, 12 (G) nucleotides, and 
different numbers of repeats of consecutive GGH codons. As shown in Figure S3B, these 
(G)-rich nucleotide sequences could induce NGD, and the 12 (G) sequence induced NGD 
more efficiently than 6 repeats of GGH codons. It has been shown that the sequence 
r(GGAGGAGGAGGA) forms an intra-molecular parallel quadruplex, and that two 
quadruplexes form a dimer through intermolecular hexad-hexad stacking (Mashima et al., 
 
 
2009). Therefore, it is likely that the 12 repeats of the GGN codon may form stable 
quadruplex structure and inhibit translation elongation. Many G-quadruplex motifs have 
been mapped to ORFs (Kikin et al., 2007), and we suspect that G-quadruplex motifs may 






Figure S4. Related to Figure 4 
Polysome analysis of 3'-NGD intermediates. Crude extracts of xrn1ǻ or xrn1ǻdom34ǻ 
mutant cells harboring the indicated GFP-X-FLAG-HIS3 plasmid were analzyed by 
10-50% sucrose-gradient centrifugation. RNA prepared from each fraction was analyzed 
by Northern blotting using DIG-labeled HIS3 probe. The gray arrows indicate full-length 
GFP-X-FLAG-HIS3 mRNA, and black arrows indicate the 3’ HIS3 fragment produced by 






Figure S5. Related to Figure 5. 
(A) Schematic drawing of the HIS3 and his3-ns mRNAs. The filled boxes indicate the 
open reading frames, the line represent non-translated regions, and the tract of As denotes 
the poly(A) tail. The antisense-oligo AS1 used for RNase H treatment is shown as a bold 
line. (B) Polyadenylated his3-ns mRNAs were stabilized in an xrn1ǻ mutant. W303 (WT), 
W303dom34ǻ, W303xrn1ǻ or W303xrn1ǻdom34ǻ cells harboring an 
yCplac33GAL1p-HIS3 (pIT826) or an yCplac33GAL1p-His3-ns (pIT827) plasmid were 
grown. RNA samples were digested with RNase H after hybridization with the AS1 
oligonucleotide (5'-ACGCACTCTCACTACGGTGATGAT-3’) or with oligo dT (dT), and 











Figure S6, related to Figure 6. 
Dom34:Hbs1 is required for the complete degradation of decay intermediates of nonstop 
mRNA. W303 (WT), W303dom34ǻ, W303ski2ǻdom34ǻ or W303xrn1ǻdom34ǻ cells 
harboring a yCplac33GAL1p-HIS3 (pIT826) or yCplac33GAL1p-His3-ns (pIT827) plasmid 
were grown in SC-Gal Ura medium. RNA samples were analyzed by 6% TBE-Urea 








Figure S7. Related to Figure 7. 
The expression levels of Ski7 mutant proteins. Full-length Ski7 or Ski7-ǻCTD, a mutant 
that lacks a Ski7-CTD, or Ski7-ǻNTD, a mutant that lacks a amino terminal region of Ski7 
were expressed under the control of indicated promoters by the indicated plasmids. The 





Figure S8. Related to the Discussion 
Dom34:Hbs1 Facilitates the Degradation of Aberrant mRNA Lacking a Termination 
Codon by Dissociating the Stalled Ribosome at the 3’ End.  
(A) Dual functions of Dom34:Hbs1 in mRNA clearance coupled with translation arrest. 
The ribosome is stalled when a poly-lysine sequence (red circles) is synthesized, and 
translation arrest results in an endonucleolytic cleavage of the mRNA upstream of the 
poly(A) sequence. The Dom34:Hbs1 complex stimulates, but is not essential for this 
cleavage. The resulting 5'-NGD intermediate is stop-codon-less mRNA, and the ribosome 
is stalled at the 3’ end of this mRNA. The Dom34:Hbs1 complex is required for 
dissociation of the stalled ribosome from the mRNA, and for degradation of the 5'-NGD 
intermediate by exosomes. The resulting 3'-NGD intermediate is degraded by Xrn1 
although the stalled ribosome could inhibit this degradation.  
(B) A model for the function of Dom34:Hbs1 in quality control of nonstop mRNA. A 
ribosome is stalled at the 3’ end of the poly(A) tail of nonstop mRNA. The Dom34:Hbs1 
complex is required for the dissociation of the stalled ribosome from nonstop mRNA, and 
for degradation of the aberrant mRNA by exosomes. The nonstop mRNA is also rapidly 
degraded by Xrn1 from the 5’ end probably due to the release of the poly(A) binding 
protein which generally inhibits the decapping reaction.
 
 
Table S1. Yeast Strains and Plasmids Used in This Study,  
Related to the Experimental Procedures 
 
 
 Strain/plasmids  Genotype[plasmid](plasmid number)    Source 
Strains 
W303-1a   MATa ade2 his3 leu2 trp1 ura3 can1    Lab stock 
YIT2013*  W303-1a ski2ǻ::kanMX    Kuroha et al., 2010 
YIT2014*  W303-1a dom34ǻ::hygMX   Kuroha et al., 2010 
YIT2015*  W303-1a hbs1ǻ::natMX    Kuroha et al., 2010 
YIT2016*  W303-1a ski2ǻ::kanMX dom34ǻ::hygMX  Kuroha et al., 2010 
YIT2017*  W303-1a ski2ǻ::kanMX hbs1ǻ::natMX   Kuroha et al., 2010 
YIT2019*  W303-1a xrn1ǻ::kanMX    Tsuboi et al., 2010 
YIT2020  W303-1a xrn1ǻ::kanMX dom34ǻ::hygMX  This study 
YIT2021  W303-1a xrn1ǻ::kanMX hbs1ǻ::natMX  This study 
YIT2022  W303-1a ski7ǻ::natMX    This study 
YIT2023  W303-1a ski7ǻ::hygMX dom34ǻ::kanMX  This study 
YIT2024  W303-1a ski2ǻ::kanMX pth1ǻ::hygMX pth2ǻ:: natMX This study 
 
plasmids  
p416GPDp  URA3 CEN      Mumberg et al., 1995 
p415GPDp  LEU2 CEN      Mumberg et al., 1995 
p415TEFp  LEU2 CEN      Mumberg et al., 1995 
p415ADHp  LEU2 CEN      Mumberg et al., 1995 
p414GPDp  TRP1 CEN      Mumberg et al., 1995 
p416GAL1p  URA3 CEN      Mumberg et al., 1994 
yEplac195  URA3 2mu     Gietz and Sugino, 1988 
pIT826  yCplac33GAL1p-FLAG-HIS3   Inada and Aiba, 2005 
pIT827  yCplac33GAL1p-FLAG-his3-ns   Inada and Aiba, 2005 
pSA144  p416GPDp-GFP-FLAG-HIS3    Dimitrova et al., 2009 
pIT2004  p416GPDp-GFP-R12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2007  p416GPD-GFP-F12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2008  p416GPD-GFP-E12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2009  p416GPD-GFP-L12-FLAG-HIS3   Dimitrova et al., 2009 
pIT2010  p416GPD-GFP-I12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2011  p416GPD-GFP-M12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2012  p416GPD-GFP-V12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2013  p416GPD-GFP-S12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2014  p416GPD-GFP-P12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2015  p416GPD-GFP-T12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2016  p416GPD-GFP-A12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2017  p416GPD-GFP-Y12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2018  p416GPD-GFP-H12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2019  p416GPD-GFP-N12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2020  p416GPD-GFP-D12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2021  p416GPD-GFP-C12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2022  p416GPD-GFP-W12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2023  p416GPD-GFP-Q12-FLAG-HIS3    Dimitrova et al., 2009 
pIT2024  p416GPD-GFP-G(Gly)12-FLAG-HIS3   Dimitrova et al., 2009 
 
 
pIT2025  p416GPD-GFP-W12-FS-FLAG-HIS3    Dimitrova et al., 2009 
pIT2051   p416GPDp-GFP-K12(AAA)-FLAG-HIS3  Dimitrova et al., 2009 
pIT2052  p416GPDp-GFP-SL-FLAG-HIS3    Dimitrova et al., 2009 
pIT2090  p416GPDp-GFP-GNG12-FLAG-HIS3   This study 
pIT2091  p416GPDp-GFP-GUG12-FLAG-HIS3   This study 
pIT2092  p416GPDp-SL-GFP-GNG12-FLAG-HIS3   This study 
pIT2093  p416GPDp-SL-GFP-GUG12-FLAG-HIS3   This study 
pIT2094  p416GPDp-GFP-GGN6-FLAG-HIS3    This study 
pIT2095  p416GPDp-GFP-(G8A)2-FLAG-HIS3    This study 
pIT2096  p416GPDp-GFP-G12-FLAG-HIS3    This study 
pIT2097  p416GPDp-GFP-GGH12-FLAG-HIS3   This study 
pIT2098  p416GPDp-GFP-GGH10-FLAG-HIS3   This study 
pIT2099  p416GPDp-GFP-GGH8-FLAG-HIS3    This study 
pIT2100  p416GPDp-GFP-GGH6-FLAG-HIS3    This study 
pIT2101  p416GPDp-GFP-rare-FLAG-HIS3    This study 
pIT2102  p416GALp-GFP-GGN12-FLAG-HIS3    This study 
pIT2103  p416GALp-GFP-SL-FLAG-HIS3    This study 
pIT2104  p416GAL1p-GFP-FLAG-HIS3    This study 
pIT2105  p416GAL1p-GFP-Rz-FLAG-HIS3    This study 
pIT2106  yEPlac195GAL1p-FLAG-HIS3    This study 
pIT2107  yEPlac195GAL1p-FLAG-his3-ns    This study 
pIT2108  p416GPDp-GFP-Rz-FLAG-HIS3    Kobayashi et al., 2010 
pIT2109  p415GPDp-Dom34-FLAG LEU2 CEN   Kobayashi et al., 2010 
pIT2110  p415GPDp-Dom34-F47A-FLAG LEU2 CEN   Kobayashi et al., 2010 
pIT2111  p415GPDp-Dom34-ǻ(47-60)-FLAG LE2 CEN   Kobayashi et al., 2010  
pIT2112  p414GPDp-yhbs1-FLAG TRP1 CEN   Kobayashi et al., 2010 
pIT2113  p414GPDp-yhbs1-T232A-FLAG TRP1 CEN  Kobayashi et al., 2010 
pIT2114  p414GPDp-yhbs1-H255A-FLAG TRP1 CEN  Kobayashi et al., 2010 
pIT2115  p415GPDp-FLAG-Ski7 LEU2 CEN   This study 
pIT2116  p415TEFp-FLAG-Ski7 LEU2 CEN   This study 
pIT2117  p415ADHp-FLAG-Ski7 LEU2 CEN   This study 
pIT2118  p415GPDp-FLAG-Ski7-ǻCTD LEU2 CEN  This study 
pIT2119  p415TEFp-FLAG-Ski7-ǻCTD LEU2 CEN  This study 
pIT2120  p415ADHp-FLAG-Ski7-ǻCTD LEU2 CEN  This study 
pIT2121  p415ADHp-FLAG-Ski7-ǻNTD LEU2 CEN  This study 
pIT2122  p416GALp-GFP-rare-FLAG-HIS3    This study 
pIT2123  p416GALp-GFP-K12-FLAG-HIS3    This study 
pIT2124  p416GALp-RNA14     This study 




Table S2. List of Oligonucleotides Primers Used for Plasmid Construction, 
Related to the Experimental Procedures 
 
 
Gene Name     Primers for PCR 
 
GFP-GNG12-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’and 
 5’-GGACTAGTGTCCGCCACCTCCGCCACCTCCGCCACCTCCGCCACGCTAGTTTT 
 GTATAGTTCATCC-3’ 
GFP-GUG12-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’and  
 5’-GGACTAGTGTCCACCACCACCACCACCACCACCACCTCCACCACGCTAGTTT 
 TGTATAGTTCATCC-3’ 
GFP-GGN12-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 
 5’-CTAGCGGTGGCGGAGGGGGTGGCGGAGGGGGTGGCGGAGGGA -3’  
GFP-GGN6-FLAG-HIS3 5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’and  
 5’-GGACTAGTGCCACCCCCTCCGCCACCGCTAGTTTTGTATAGTTCATCC -3’ 
GFP-(G8A)2-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 
 5’-GGACTAGTTCCCCCCCCTCCCCCCCCGCTAGTTTTGTATAGTTCATCC -3’ 
GFP-G12-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’and  
 5’-GGACTAGTCCCCCCCCCCCCGCTAGTTTTGTATAGTTCATCC-3’ 
GFP-GGH12-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 
 5’-GGACTAGTTCCGCCACCTCCGCCACCTCCGCCACCTCCGCCACCGCTAGTTTT 
 GTATAGTTCATCC -3’ 
GFP-GGH10-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’and 
 5’-GGACTAGTACCTCCGCCACCTCCGCCACCTCCGCCACCGCTAGTTTTGTATAG 
 TTCATC -3’ 
GFP-GGH8-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and 
 5’-GGACTAGTGCCACCTCCGCCACCTCCGCCACCGCTAGTTTTGTATAGTTCATC 
 C -3’  
GFP-GGH6-FLAG-HIS3  5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’and 




Table S3. List of Oligonucleotides Used for DIG-Labeled Probes, 
Related to the Experimental Procedures 
 
 
Probe Name        DIG-label method  oligonucleotide sequences 
 
GFP  Internal label (PCR) 5’-GCTCTAGAATGAGTAAAGGAGAAGAACTTTTCAC-3’ and  
    5’-GGACTAGTTTTGTATAGTTCATCCATGCCA-3’ 
G1 (GFP 1-75)  5’ end label 5’-CCCATTAACATCACCATCTAATTCAACAAGAATTGGGAC 
    AACTCCAGTGAAAAGTTCTTCTCCTTTACTC-3’ 
G2 (GFP 321-385) 5’ end label 5’-CAATACCTTTTAACTCGATACGATTAACAAGGGTATCAC 
    CTTCAAACTTGACTTCAGCACGCGTC-3’ 
G3 (GFP 654-714) 5’ end label 5’-TTTGTATAGTTCATCCATGCCATGTGTAATCCCAGCAGC 
    AGTTACAAACTCAAGAAGGACC-3’ 
3’UTR (HIS3)  Internal label (PCR) 5’-CGGGATCCTAGTGACACCGATTATTTAAAGCTGC-3’ and  
    5’-GGAATTCCTCGTTCAGAATGACACGTA-3’ 
ORF (HIS3)  Internal label (PCR) 5’-GCTCTAGAGTCACTGCCAGGTATCGTT-3’ and  
    5’-CGGGATCCCATAAGAACACCTTTGGTGGAGG-3’ 
NS1 (-52~+20 of stop codon) 5’ end label 5’-CTTACTGACATTCATAGGTATACATATATACACATGTAT 
    ATATATCGTATGCTGCAGC-3’ 
NS2 (+21~+79 of stop codon) 5’ end label 5’-TTTAAATAATCGGTGTCACTGGATCCCATAAGAACACCT 
    TTGGTGGAGGGAACATCGTTGGTACCATTGG-3’ 
NS3 (+80+149 of stop codon) 5’ end label 5’-CGTTCAGAATGACACGTATAGAATGATGCATTACCTTGT 
    CATCTTCAGTATCATACTGTTCGTATACATA-3’ 
LNA-dT  5’ end label 5’-tTtTtTtTtTtTtTtTtTtTt-3’ (LNA is indicated by upper case) 
RNA14  Internal label (PCR) 5’-CGGGATCCATGTCCAGCTCTACGACTCCTGATTTAC-3’ and  
   5’-CCATCGATGATCCGAATTTTCAGATATATACATTGAATA 
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